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ABSTRACT OF THE DISSERTATION
REAL-TIME BIOSENSOR FOR THE ASSESSMENT OF NANOTOXICITY AND
CANCER ELECTROTHERAPY
by
Evangelia Hondroulis
Florida International University, 2013
Miami, Florida
Professor Chenzhong Li, Major Professor
Knowledge of cell electronics has led to their integration to medicine either by
physically interfacing electronic devices with biological systems or by using electronics
for both detection and characterization of biological materials. In this dissertation, an
electrical impedance sensor (EIS) was used to measure the electrode surface impedance
changes from cell samples of human and environmental toxicity of nanoscale materials in
2D and 3D cell culture models. The impedimetric response of human lung fibroblasts
and rainbow trout gill epithelial cells when exposed to various nanomaterials was tested
to determine their kinetic effects towards the cells and to demonstrate the biosensor’s
ability to monitor nanotoxicity in real-time. Further, the EIS allowed rapid, real-time and
multi-sample analysis creating a versatile, noninvasive tool that is able to provide
quantitative information with respect to alteration in cellular function.
We then extended the application of the unique capabilities of the EIS to do realtime analysis of cancer cell response to externally applied alternating electric fields at
different intermediate frequencies and low-intensity. Decreases in the growth profiles of
the ovarian and breast cancer cells were observed with the application of 200 and 100
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kHz, respectively, indicating specific inhibitory effects on dividing cells in culture in
contrast to the non-cancerous HUVECs and mammary epithelial cells. We then sought to
enhance the effects of the electric field by altering the cancer cell’s electronegative
membrane properties with HER2 antibody functionalized nanoparticles. An Annexin
V/EthD-III assay and zeta potential were performed to determine the cell death
mechanism indicating apoptosis and a decrease in zeta potential with the incorporation of
the nanoparticles. With more negatively charged HER2-AuNPs attached to the cancer
cell membrane, the decrease in membrane potential would thus leave the cells more
vulnerable to the detrimental effects of the applied electric field due to the decrease in
surface charge. Therefore, by altering the cell membrane potential, one could possibly
control the fate of the cell.

This whole cell-based biosensor will enhance our

understanding of the responsiveness of cancer cells to electric field therapy and
demonstrate potential therapeutic opportunities for electric field therapy in the treatment
of cancer.
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Chapter 1

INTRODUCTION
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1.1 Motivation
Electrically directed and coordinated cell movement plays a significant role in
mammalian cell behavior starting from embryonic development. Cells have intrinsic
electrical properties which determine how they are affected under different stimuli.
Understanding these electrical properties will lead to further information on how the cell
functions allowing the cells to be used as sensors for monitoring cellular behavior.
The motivation behind this doctoral study is to analyze the electronic properties of
cells by using a whole cell electrical impedance sensing (EIS) biosensor to monitor their
behavior in real-time. The capability of the biosensor to monitor the cellular behavior
was first demonstrated by testing human and environmental toxicity of nanoscale
materials in 2D and 3D cell culture models, and then the biosensor was ultimately used to
test the effects of external alternating electric fields in combination with antibody
targeted nanoparticle therapy on the behavior of cancer cells. The biosensor provides a
rapid, real-time and multi-sample technique to get more information about living cells
without disturbing the cellular sub-systems creating a versatile, noninvasive tool that is
able to provide quantitative information with respect to alteration in cellular function
when subjected to the various stimuli. Studying nanotoxicity demonstrated the ability of
the EIS biosensor to monitor the kinetic effects of the cellular reaction pattern towards
various nanoparticles, allowing better understanding of the nanoparticle-cell interaction
over time. The cancer electrotherapy study improved our fundamental understanding of
the behavior of cancer cells to alternating electric fields and allowed us to define a
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strategy and optimal parameters of antibody targeted nanoparticle electrotherapy for
clinical and drug delivery applications.
1.2 Background
Biosensors are becoming valuable tools for analyzing various physical, chemical
and biological processes. Since 1962 when Professor Leland C. Clark Jr. first published
a paper on the oxygen electrode [1], researchers have incorporated and enhanced
biosensing technology in fields such as in health care, the food industry and
environmental monitoring.

The attraction to biosensors stems from their accurate,

precise, reproducible measurements in a cheap, small, portable fashion. Most current
biosensors are used to detect enzymes, DNA/RNA and immunological components
converting the biological phenomena into electrical signals [2-4] allowing for specifically
targeted results. Whole cell impedance based biosensors, pioneered by Giaever and
Keese (1984), were developed to monitor proliferation and motion of a population of
anchorage dependent cell cultures. By monitoring whole cell activity, one can monitor
changes in membrane receptors, channels, and enzymes that may be expressed by the
cell. Morphological changes can also be monitored using EIS biosensors since cellular
membranes exhibit dielectric properties [5]. EIS biosensors are especially beneficial for
monitoring whole cell behavior because they provide information about the total
physiological responses of cells to external stimuli. Biosensors that incorporate whole
cells can have an advantage over other biosensors for certain applications because they
can provide functional information without damaging the cells.
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Nanotechnology has great potential benefits in rapidly developing fields such as
biomedical engineering, drug delivery, environmental health, pharmaceutical industries
and even electronics and communication technologies. For instance, in the healthcare
field, nanomaterials are being considered in the development of new drugs and new
therapies for disease control and improving the quality of life [6-8]. More recently,
nanomaterials have been used in tissue engineering and medical imaging, leading to
improved diagnostics and new therapeutic treatments [9-11]. However, with this rapid
development, these new nanoscale materials (including nanotubes, nanowires,
nanowhiskers, fullerenes or buckyballs and quantum dots) might have unintended
hazards for human health and the environment [12-13]. Current in vitro techniques to
measure nanotoxicity, including mitochondrial reduction of tetrazolium salts into an
insoluble dye (the MTT test) and enzyme lactate dehydrogenase (LDH) release tests are
used as markers for cell viability and provide only a final measurement of toxicity to a
cell culture overlooking the ongoing cytotoxic effects of the nanoparticles over time. EIS
biosensors are ideal for detecting toxic nanomaterials in industrial products, chemical
substances, environmental samples (e.g. air, soil and water) or biological systems (e.g.
bacteria, viruses or tissue components) as they are able to monitor the progression of the
cytotoxicity in real time demonstrating the kinetic effects of the nanomaterials towards
whole cells.
Living cells are associated with electrical characteristics and are thus responsive
to and even generate electric fields and currents. Cells control the exchange of electrically
charged ions across their membrane creating a membrane potential with different
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amounts of electrical charges inside and outside the cell. A shift in membrane potential
will alter the exchange of ions across it and vice versa. For instance, it has been shown
that alteration in membrane potential can alter the signal pathways involved in mitosis of
the cell and thus its proliferation [14]. Recently, there has been interest in the use of
electrotherapy as a treatment for cancer. Since the electrical properties of cancer cells
differ from normal proliferating cells, electric fields may induce differential effects in
normal and cancerous cells. For example, cancer cells exhibit a lower electrical potential
of their membrane compared to healthy cells. Cancer cells also exhibit disorganized
growth, weak interactions with their neighboring cells and do not exhibit contact
inhibition of their growth [15]. Consequently further research is warranted to establish
the role of electric field therapy for the treatment of cancer.
1.3 Cell Electronics
Electrically directed and coordinated cell movement plays a significant role in
mammalian cell behavior starting from embryonic development. Cells have intrinsic
electrical properties that fuel this behavior, the most prevalent stemming from the cellular
membrane consisting of a lipid bilayer riddled with various transmembrane proteins
creating ionic channels responsible for the survival of the cell. Due to these channels, the
membrane can be considered to have mostly capacitive properties with the inside of the
cell more resistive creating a membrane potential (Figure 1.1). Understanding these
electrical properties of the cell and how they are affected under different stimuli, we can
find out more information on how the cell functions.
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Changes in these electrical

properties allow the cells to be used as sensors for monitoring cellular behavior under
various stimuli.

Figure 1.1 - A cell can be thought of as a circuit made up of capacitors and resistors with the membrane
acting like a capacitor and the the cytosol as a resistor. (Source: biotele.com. Image by Bryan Christie)

Cells have electrostatic forces due to the charged ions within the cell creating an
electric field creating the cell’s permittivity, the ability to form an electric field, and its
conductivity, the ability to conduct an electric current. Cells also have electromotive
forces to maintain a required potential difference such as voltage, current, resistance, and
capacitance.

All these properties are found in developing, wounded, normal, and

diseased tissues and are the center of various technologies such as dielectrophoresis,
electroporation, and impedance spectroscopy.
The structure of the cellular membrane plays an important role in the electronic
properties of the cell. The cell membrane creates the boundary between the regulated
internal environment of the cell and the external environment.

The membrane is

constructed from molecules with long fatty chains with electrically charged head groups
in contact with the surrounding water allowing it to be water soluble.
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Within the

membrane structure are various types of proteins responsible for a variety of cellular
functions. The integral proteins, passing through the cell membrane, and the peripheral
proteins, lining the inside and outside of the membrane, give the cell control of motion,
transport of molecules, and adhesion to surfaces. The integral proteins are the ones that
form pumps that actively transport ions across the cell membrane developing the
transmembrane potential.

Since the membrane is semipermeable to certain ions, a

concentration gradient forms causing a potential to develop across the membrane as
defined by the Nernst equation:
  

𝐸𝐸 =   

𝑅𝑅𝑅𝑅 [𝑆𝑆]
ln
𝐹𝐹
[𝑆𝑆]

where Es is the equilibrium potential [S]1 and [S]2 represent the concentrations of the ion
. GF =9;@ KA<= G> L@= E=E:J9F=  - AK L@= ?9K ;GFKL9FL   % Y &-1 Y EGD-1) and F is
Faraday’s constant (9.648 x 104 YEGD-1). Concerning the cell membrane, the ions of
interest are K+, Na+, Ca2+, and Cl- with potassium and chloride creating negative and
sodium and calcium creating positive intracellular potential with respect to the
extracellular potential. For most electrically active cells, there is a higher concentration
of K+ ions on the inside of the cell and a higher concentration of Na+ and Cl- on the
outside creating an overall negative transmembrane potential. Changes in the cell’s
membrane potential cause action potentials, electrical signals that send messages around
the body to perform the appropriate reaction.
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The origin of measuring the electrical activity of cultured cells involved the use of
micropipettes or microwire electrodes to measure the transmembrane potential.
However, this technique, consisting of inserting a micropipette electrode through the
membrane, has its downfalls. The interface between the cell and the microelectrode is
unstable and thus limits the duration of the experiment and do not provide information
about long-term temporal changes and can potentially cause damage to the cell. The
setup is also designed to record from only a single cell at a time and thus is laborious and
low-throughput [16- 18]. To get long term recordings and non-invasively monitor the
electrical activity in terms of impedance and/or physiologic state of cultured cells planar
microelectrode array biosensors were developed in the 1970s [19].
1.4 Biosensors
Knowledge of these electrical properties of cells has led to the development of the
field of bioelectronics. Bioelectronics is the application of electronics to biology and
medicine and can be broken down into two categories. Physically interfacing electronic
devices with biological systems has led to technologies such as the cardiac pacemaker,
implantable electrical bone growth simulators, deep brain simulators and electrical nerve
simulation [20]. The other aspect of bioelectronics is electronics for both detection and
characterization of biological materials, such as on the cellular and subcellular level.
This can be seen in the example of cell based biosensors that use live cells as sensing
elements to monitor physiological changes induced by internal aberration or external
stimuli [21].
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A biosensor is commonly defined as a device that detects, records, and transmits
information regarding a physiological change or process.

Biologically derived

recognition entities (enzymes, antibodies, microorganisms, cell receptors, cells, etc.) are
coupled to a transducer which detects the biological reaction and converts it into a signal
which can be physicochemical, optical, electrochemical, thermometric, or magnetic
(Figure 1.2)[22].

Figure 1.2 - Schematic of biosensors

Biosensing technology has spread throughout many disciplines due to its great
specificity, sensitivity, and diversity in uses. Molecular and enzymatic biosensors were
among the first to be introduced in the 1970’s [23-24] with thermal, optical and
electrochemical following shortly thereafter [25-28].
1.5 Electrical Impedance Sensing Biosensor
Planar microelectrode biosensors used to monitor cellular behavior were first
introduced by C.A. Thomas, et al. in 1972 to monitor the electrical activity of contracting
embryonic chick heart cells [19]. Since then, microelectrode biosensors have been used
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to study cell cultures in vitro under different conditions. For instance, Gross et al. used a
microelectrode biosensor to monitor and eventually stimulate neuronal cell activity in
vitro from the brain and spine [29-31]. Other uses include monitoring metabolism [32],
fluorescent probes and reporter genes [33], and electrophysiology [34].
Whole cell electrical impedance based biosensors pioneered by Giaever and
Keese (1984) were the first demonstration of a system capable of monitoring proliferation
and motion of a population of anchorage dependent cell cultures in vitro [35]. Giaever
and Keese cultured human lung fibroblasts cells on modified cell culture dishes
consisting of a large reference electrode (2 cm2) and 4 smaller electrodes (3 x 10-4 cm2).
They applied an AC voltage through a resistor to a single small electrode in the dish
resulting in a constant current source which enabled the impedance to be determined by
measurement of the resulting voltage. They were able to observe the effects of cell
proliferation (impedance increase) as well as the micromotion of the cells (fluctuations in
observed impedance).
Giaever and Keese then used their biosensor to examine the effects of different
proteins on cell adhesion, spreading, and motility [36]; to create a mathematical model of
cell motion [37]; the use of this impedance method in cell based sensor applications [3840]. Connelly et al. modified Giaever and Keese’s biosensor design by adding a glass
ring around the electrode area to contain the cell culture media and inserting a permeable,
cellulose nitrate membrane to separate the culture dish into two sides, each with two
measurement electrodes creating a control and a test electrode [41].
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1.6 Nanotoxicity
Testing for toxicological parameters is a necessary first step toward ensuring the
compatibility of nanomaterials for medical applications and for the safety of the
environment. The properties of metals change when they are in the nanoscale and they
may pose certain threats to biological systems that their bulk counterparts may not. To
date, nanotoxicity is a crucial topic that is being addressed by a number of studies [4244]; however, there is a lack of consensus in the published literature on nanoparticle
toxicity due to the variability of methods, materials and cell lines used [45]. With the
increase in research and commercial use of these nanomaterials, standardization of
methods in nanotoxicity testing is becoming increasingly important to validate these
novel techniques.
The main risk associated with the use and manufacture of nanomaterials is human
and environmental exposure. One of the more common impacts of the use of
nanomaterials is the emission of hazardous air pollutants which contain particulate matter
on the order of 1–100 nm in size. Any material in the respirable size range, less than 100
nm in diameter, may have toxic effects on the lung fibroblasts after inhalation [46]. In
particular, nanoparticles with sizes less than 20 nm affect the alveolar region of the lung
[47]. The use of nanomaterials in biomedical sciences has placed nanomaterials directly
in contact with biological materials, and thus it is necessary to observe their interaction
closely.

11

In the environment, nanotechnology is being used to solve problems such as soil
and groundwater remediation, air purification, pollution detection and sensing [48-50].
Manufactured nanoparticles are being engineered for projects that will benefit the
environment as well in the form of environmental cleanup tools. For instance, in the UN
Millennium Project, fullerenes are being used to absorb various toxins and iron
nanoparticles to catalyze the breakdown of solvents. There have been debates on whether
the disposal of these manufactured nanoparticles causes significant harm to the
environment as there is a lack of validated protocols for their disposal and removal [51].
A particular nanomaterial that is of interest is graphene, with its simple structure,
single-atom–thick sheets of carbon, its potential in the scientific world has been quite
intense. Due to its unique features, researchers have rushed to study its many potential
applications such as nanoelectronic devices, transparent conductors and nanocomposites
[52-53], while possibly overlooking any potential hazards. The cytotoxic effects of other
carbon nanomaterials such as fullerenes, nanotubes and nanoﬁbers have been studied
before with mixed results [54]. The general consensus for the cause of cytotoxicity of
these materials seems to be due to their byproducts or residues such as metal traces and
amorphous carbon which cause oxidative stress to the cells [55-57]. The cytotoxic
effects of graphene may be different than those of other graphitic materials as
cytotoxicity studies on graphene are far and few between.
Biomedical engineering applications using graphene have surfaced recently in the
form of biosensing devices [58], enzymatic biofuel cells [59], microbial detection,
disease diagnosis and drug delivery systems [60], creating a cell-graphene interface that

12

must be explored further. Although similar in chemical composition, graphene compared
to its carbon counterparts may behave differently when interacting with biological
elements as it lacks the transition metals, Fe, Ni etc. that are present with carbon
nanotubes for example, leading to its high purity [61]. It has been shown that cells could
grow on graphene sheets [62]; however, one must still examine the cellular interaction of
graphene as a nanomaterial as the graphene’s properties may change and may produce
certain threats to the biological systems that its bulk counterpart may not.
One major potential application of carbon based nanomaterials is for drug
delivery. The use of nanomaterials for targeted drug delivery is becoming a popular topic
of interest in the field of biomedical engineering with many recent advances.

For

instance, Liu et al. recently tested single walled carbon nanotubes as carriers for the drug
paclitaxel to target tumors in mice and showed higher ratios of tumor to normal organ
uptake of the drug-carbon nanotube combination [63]. Using nanomaterials to transport
the desired drug prevents unwanted side effects since the drug is targeted only in the
desired site, and can minimize drug dilution throughout the body increasing the drug
concentration delivered to the pathological area. Graphene and graphene oxide with their
unique properties are on the forefront of this technology [64].
One area of interest in particular to drug delivery is the blood brain barrier (BBB),
a tight seal of endothelial cells that lines the blood vessels in the brain that selectively
allows the entry of certain molecules from blood circulation into the brain. Maintaining
the integrity of the BBB is an important issue when designing a drug delivery system and
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thus the interaction of these graphene nanomaterials with the BBB must be explored
further.
Traditional biological methods for measurement of cellular activity and
proliferation are used in current nanotoxicity studies. These methods include
mitochondrial reduction of tetrazolium salts into an insoluble dye (the MTT test) and
enzyme lactate dehydrogenase (LDH) release tests. These methods are used as markers
for cell viability and consist of procedures that provide a general sense of cytotoxicity as
they show results only at a final time point [65].

As a result, the kinetic model

(absorption, distribution, metabolism and excretion) of the nanoparticle uptake is not
usually observed with these conventional methods. Following biological exposure, the
particles may transport across cell membranes, especially into mitochondria, causing
internal damage that may affect cell behavior and over time, lead to cell death [66].
Integration of biomolecules with nanotechnology has great future perspectives in
rapidly developing fields of environmental (pollution control and monitoring),
biomedical research, drug delivery, electronics and communication technologies. With
the increasing number of nanomaterial applications, assessing their toxicity should be the
first important step toward creating safety guidelines for their handling and disposal.
Studies of biological effects of nanoscale materials that might answer these questions
have lagged behind other aspects of nanotechnology development. EIS technology is
shown to be sensitive enough to measure the micro-motion of a cell and therefore able to
monitor the progression of the cytotoxicity with rapid, real-time and multi-sample
analysis creating a versatile, noninvasive tool that is able to provide quantitative
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information with respect to alteration in cellular function under various nanomaterial
exposures.
1.7 Cancer Electrotherapy
Currently, 1 in 4 deaths in the United States is due to cancer with a total of
1,596,670 new cancer cases and 571,950 deaths from cancer projected to occur in the
United States in 2011 [67]. Current advancements in cancer treatments such as surgery,
radiotherapy and chemotherapy have proven to be successful, however, with many side
effects. Surgery is the best chance of cure for many cancers that have not spread,
however, as with all surgeries, there are complications. Radiotherapy, the use of ionizing
radiation to damage the DNA of exposed cells, kills cancer cells in and around a specific
tumor however, it also kills surrounding normal cells producing deleterious side effects
known as radiation toxicities. Chemotherapy, the use of drugs to destroy cancer cells is
beneficial in destroying cancer cells that may have spread, however, like radiotherapy; it
also kills the surrounding healthy cells.
The effects of exogenous electric fields on physiology and their possible
relationship to diseases have interested researchers for years [68-70].

In 1855,

Guillaume Duchenne discovered that alternating current leads to electrotherapeutic
triggering of muscle contractions thus spurring the use of electrical energy as medical
treatment. Since then, the use of electric fields has become popular in fields such as gene
and cellular therapies [71-73], and has even progressed to clinical trials for drug delivery
[74], however; still little is known how electric fields may interact with intracellular
signaling pathways to potentially alter cell physiology.
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Living cells are associated with electrical characteristics including resting
membrane potential, ionic current flow, resistance, capacitance, permittivity, and
conductivity and are thus responsive to and even generate electric fields and currents.
The idea of classifying cancers by their electrical properties was first proposed by Fricke
and Morse in 1926 [75]. Recently, there has been interest in the use of electrotherapy as
a treatment for cancer. Since the electrical and physical properties of cancer cells differ
from normal proliferating cells, electric fields may induce differential effects in normal
and cancerous cells. For example, cancer cells exhibit a lower electrical potential of their
membrane compared to healthy cells. Cancer cells also exhibit disorganized growth,
weak interactions with their neighboring cells and do not exhibit contact inhibition of
their growth. Consequently further research is warranted to establish the role of electric
field therapy for the treatment of cancer.
Current treatments for cancer have much potential; however, a major limitation in
these treatments is the negative side effects that occur.

Electrotherapy for cancer

treatment is very promising alternative as it eliminates the toxic chemicals and possible
immunogenic responses in the host tissue.

The outcome of this research will improve

our fundamental understanding of the behavior of cancer cells to alternating electric
fields and define a strategy and optimal parameters of electrotherapy for clinical and drug
delivery applications. This whole cell-based biosensor will enhance our understanding of
the responsiveness of cancer cells to electric field therapy and demonstrate potential
therapeutic opportunities for electric field therapy in the treatment of cancer.
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1.8 Specific Aims
Specific Aim 1 - Electronic Platform for Monitoring Cellular Behavior – Nanotoxicity
Task 1: Testing reproducibility and sensitivity of EIS biosensor
Electrochemical testing of the EIS biosensor is done to ensure consistent and
accurate readings for every experiment. We tested the reproducibility and sensitivity of
the EIS biosensor by performing cyclic voltammetry, one of the most widely used
techniques for acquiring qualitative information about electrochemical reactions. In situ
biosensor testing also allows for rejection of biosensors which might have been damaged
due to improper storage or handling (e.g. at excessive temperatures) ensuring accurate
data. We achieved consistent cyclic voltammograms among the electrodes of the EIS
biosensor demonstrating its high reproducibility and sensitivity.
Task 2: Nanoparticle preparation and characterization
Characterization of the nanomaterials to be tested is necessary as specific
properties of the materials depend on their size and purity. Most cell types undergo
phagocytosis or endocytosis to eliminate large particles that interact with the cell
membrane; however, the smaller sized particles may bypass the natural mechanical
barriers of the cells which may result in severe tissue damage [76]. Once inside the cells,
the nanoparticles may interfere with the functions of the cell’s organelles and other
biomolecular structures leading to damage and even death of the cell. The exact
mechanisms of this process are still not fully understood [77-78].
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After selecting various nanomaterials for testing, gold (AuNPs), silver (AgNPs),
and single wall carbon nanotubes (SWCNTs), we manufactured and prepared these
materials for the nanotoxicity study. Once made, we characterized the materials using
transmission electron microscopy (TEM). The SWCNTs used in this study were purified
in diluted acids to prevent unwanted contamination of impurities such as amorphous
carbon, graphite and catalyst metal particles which may reside on the tubes. The AuNPs
and AgNPs were fabricated at different sizes (10 and 100 nm) to further understand the
size effects of the particles and the underlying mechanisms that govern the uptake of
nanoparticles into cells.
Task 3: Real-time detection of nanotoxicity on 2D and 3D living cell models
Traditional biological methods for measurement of cellular activity and
proliferation are used in current nanotoxicity studies. These methods include the MTT
assay and the LDH release test which are used as markers for cell viability and consist of
procedures that provide a general sense of cytotoxicity as they show results only at a final
time point. As a result, the kinetic model (absorption, distribution, metabolism and
excretion) of the nanoparticle uptake is not usually observed with these conventional
methods.
The EIS biosensor is capable of monitoring cellular behavior electronically in
real-time. By monitoring the toxicity of a known toxin, cadmium oxide (CdO), towards
cells, we were able to confirm the suitability of the EIS biosensor for our further studies.
Once this was done, we continued on to test the toxicity of other nanomaterials for better
understanding of their interaction with different 2D living cell models (human lung
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fibroblasts (CCL-153) and rainbow trout gill epithelial cells (RTgill-W1)). We also
performed another impedance based technique, Trans Endothelial-Electrical Resistance
(TEER), to measure the toxicity of graphene on a 3D BBB tissue model. We used the
EIS to monitor the effects of graphene towards the individual components of the 3D
tissue model (rat astrocytes (CRL-2006™) and mouse endothelial cells (CRL-2583™)).
Specific Aim 2 - Electronic Platform for Monitoring Cellular Behavior – Cancer
Electrotherapy
Task 1: Determination of optimal frequency
Recently, there has been interest in the use of electrotherapy as a treatment for
cancer. Since the electrical and physical properties of cancer cells differ from normal
proliferating cells, electric fields may induce differential effects in normal and cancerous
cells. We tested various frequencies (50, 100, 150, 200 kHz and 2 MHz) of low intensity
alternating electric fields on the behavior of human ovarian cancer cells (SKOV3) in
order to determine an optimal frequency that will hinder the cell proliferation for this cell
line. Tests were also performed on non-cancerous endothelial cells (HUVECs) for a
comparison. After testing this range of frequencies of low intensity alternating electric
fields on both types of cancer cells, we obtained an optimal frequency of 200 kHz for the
SKOV3 by analyzing the change in the resistance values with and without the applied
field. We noticed no significant effect of the fields at any of the frequencies on the noncancerous cells demonstrating that this method is detrimental to cancer cells only.
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Task 2: Focus on optimal frequency
Once the optimal frequency was determined, other studies were performed using
these particular frequencies to find the appropriate parameters to ultimately create an
ideal method for cancer electrotherapy treatments. To understand how the low intensity
alternating electric fields affect the cell behavior, the field was applied at the beginning of
the experiment and also after the cells had attained a confluent monolayer.

Digital

images were taken at various time points throughout the experiment to observe any
changes in the cell morphology.
After applying the electric field to a confluent cell layer, we noticed a decrease in
the resistance values indicating disruption in the cell proliferation. We documented the
changes in the cell morphology with the digital images taken before and after the field
was applied. Two additional methods for measuring cell viability after exposure to the
alternating electric fields were performed to justify the results obtained by the EIS.
Immunofluorecence images were taken using Propidium Iodide, a fluorescent molecule
that binds to the DNA of cells, and a cell viability assay was performed using Trypan
Blue, a dye that cannot penetrate the intact cell membranes of viable cells.
Task 3: Other types of cancer cells
According to Kirson et al. [79], different types of cancer cells react to alternating
electric fields differently. It was observed that this difference was frequency dependent
since the cell membrane electric impedance properties are dependent on frequency.
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After completing Tasks 1 and 2, we studied a different type of cancer cell line,
breast cancer cells (MCF7), to further understand the mechanism behind the
phenomenon. We tested the same frequencies as with the SKOV3 (50, 100, 150, 200
kHz and 2 MHz) of low intensity alternating electric fields in order to determine an
optimal frequency that will hinder the cell proliferation for this cell line. Tests were also
performed on non-cancerous mammary endothelial cells (MCF10A) for a comparison.
After testing this range of frequencies of low intensity alternating electric fields, we
obtained an optimal frequency of 100 kHz for the MCF7 by analyzing the change in the
resistance values.

We noticed no significant effect of the fields on the non-cancerous

cells demonstrating that this method is detrimental to cancer cells only.
Specific Aim 3: Antibody-Nanoparticle Enhancement of Cancer Electrotherapy
Task 1: Nanoparticle enhancement of electric field effects
Nanoparticles have been extensively studied for use in biomedical applications,
particularly gold nanoparticles, due to their low cytotoxicity [80]. Specifically, gold
nanoparticles are being studied for use in targeted drug deliveries to specific cells [81].
Further experiments using gold nanoparticles were performed to determine if the
nanomaterials enhance the effects of the electric fields towards the SKOV3 and MCF 7
without affecting non-cancerous HUVECs and MCF10a. We observed a lowering in the
resistance values of the SKOV3 and MCF7 cells under the electric field with presence of
the gold nanoparticles.
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Task 2: Antibody functionalization of nanoparticles for targeted delivery
HER2, human epidermal growth factor receptor 2, is a cell membrane surface-bound
receptor tyrosine kinase that is responsible for intracellular signal transduction and
ultimately cell growth and differentiation [82]. HER2 overexpression leads to cancerous
cell proliferation and is seen in cancers such as breast cancer, ovarian cancer, stomach
cancer, and even lung cancer [83].
We proposed that nanoparticles functionalized with specific antibodies to target
the cancer cells would enhance the effects of the electric field towards the cells without
affecting the non-cancerous cells due to the different membrane properties of the
cancerous cells. With the attached nanoparticles, the cell membrane is more vulnerable
to the effects of the external electric field due to the decrease in membrane potential, as
seen in the decrease in zeta potentials of the cells before and after nanoparticle
incorporation. The decrease in membrane potential would thus leave the cells more
vulnerable to the detrimental effects of the applied electric field. Finally, an Annexin V/
EthD-III assay was performed to determine whether the cell death mechanism involved
after the application of the field was apoptosis or necrosis.
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Chapter 2

WHOLE CELL BASED ELECTRICAL IMPEDANCE SENSING APPROACH
FOR A RAPID NANOTOXICITY ASSAY

This chapter was submitted as follows (with slight modifications): Hondroulis, E., Liu,
C., Li, C.Z. (2010) Whole cell based biosensing device for in vitro nanotoxicity assay at
cellular and tissue level, Nanotechnology 21, 315103.
2.1 Introduction
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Nanotechnology has great potential benefits in rapidly developing fields such as
biomedical engineering, drug delivery, environmental health, pharmaceutical industries
and even electronics and communication technologies. For instance, in the healthcare
field, nanomaterials are being considered in the development of new drugs and new
therapies for disease control and improving the quality of life. More recently,
nanomaterials have been used in tissue engineering and medical imaging, leading to
improved diagnostics and new therapeutic treatments. With the increasing number of
nanomaterial applications, assessing their toxicity should be the first important step
toward creating safety guidelines for their handling and disposal as these new nanoscale
materials (including nanotubes, nanowires, nanowhiskers, fullerenes or buckyballs and
quantum dots) might have unintended hazards for human health and the environment [12]. Current technologies to measure nanotoxicity are limited in the sense that they only
provide final time point data. Assessing the real-time effects of the nanomaterials on
cellular behavior is crucial for developing knowledge on the nanomaterial behavior.
The main risks associated with the use and manufacture of nanomaterials is
human and environmental exposure. Testing for toxicological parameters is a necessary
first step toward ensuring the compatibility of nanomaterials for medical applications and
for the safety of the environment as the properties of metals change when they are in the
nanoscale and they may pose certain threats to biological and ecosystems that their bulk
counterparts may not. One of the more common impacts of the use of nanomaterials is
the emission of hazardous air pollutants which contain particulate matter on the order of
1–100 nm in size. Any material in the respirable size range, less than 100 nm in diameter,
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may have toxic effects on the lung fibroblasts after inhalation [3]. In particular,
nanoparticles with sizes less than 20 nm affect the alveolar region of the lung [4]. More
recently, the use of nanomaterials in biomedical sciences has placed nanomaterials
directly in contact with biological materials, and thus it is necessary to observe their
interaction closely.
In the environment, nanotechnology is being used to solve problems such as soil
and groundwater remediation, air purification, pollution detection and sensing.
Manufactured nanoparticles are being engineered for projects that will benefit the
environment as well in the form of environmental cleanup tools, for example for
groundwater for remediation. For instance, in the UN Millennium Project, fullerenes are
being used to absorb various toxins and iron nanoparticles to catalyze the breakdown of
solvents. There have been debates on whether the disposal of these manufactured
nanoparticles causes significant harm to the environment as there is a lack of validated
protocols for their disposal and removal [5].
To date, nanotoxicity is a crucial topic that is being addressed by a number of
studies [6]; however, there is a lack of consensus in the published literature on
nanoparticle toxicity due to the variability of methods, materials and cell lines used [7].
With the increase in research and commercial use of these nanomaterials, standardization
of methods in nanotoxicity testing is becoming increasingly important to validate these
novel techniques. Recent studies measuring nanoparticle cytotoxicity in vitro provide a
final measurement of toxicity to a cell culture overlooking the ongoing cytotoxic effects
of the nanoparticles over the desired timeframe. Traditional biological methods for
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measurement of cellular activity and proliferation are used in current nanotoxicity
studies. These methods include mitochondrial reduction of tetrazolium salts into an
insoluble dye (the MTT test) and enzyme lactate dehydrogenase (LDH) release tests.
These methods are used as markers for cell viability and consist of procedures that
provide a general sense of cytotoxicity as they show results only at a final time point [8].
As a result, the kinetic model (absorption, distribution, metabolism and excretion) of the
nanoparticle uptake is not usually observed with these conventional methods. Following
biological exposure, the particles may transport across cell membranes, especially into
mitochondria, causing internal damage that may affect cell behavior and over time, lead
to cell death [9].
Biosensors are becoming valuable tools for detecting toxic chemical compounds
in industrial products, chemical substances, environmental samples (e.g. air, soil and
water) or biological systems (e.g. bacteria, viruses or tissue components). Most current
biosensors are used to detect enzymes, DNA/RNA and immunological components [10].
Biosensors that incorporate whole cells can have an advantage over these previous
biosensors as they are able to provide information about the total physiological effect of a
toxin towards the whole cell.
The first goal of this dissertation was to validate the use of a biosensor for
monitoring cellular behavior. We used a whole cell based array-formatted electrical
impedance sensing system (EIS) capable of monitoring cell morphological changes in
real-time to test human and environmental toxicity of nanoscale materials and to
ultimately evaluate the sensors suitability for various cytotoxicity measurements. We
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used the EIS to monitor the kinetic effects of AuNPs; 10, 100 nm, AgNPs; 10, 100 nm,
SWCNTs; cut, uncut, and CdO when in contact with human lung fibroblasts (CCL-153)
and rainbow trout gill epithelial cells (RTgill-W1). The EIS measures the resistance
produced by growing cell monolayers over electrodes and can detect changes in
resistance that may occur with changes in the cell layer after nanoparticle exposure. The
EIS offers compact structure, ease of use and the ability to measure multiple samples
simultaneously in real time, a critical feature in monitoring cytotoxicity. Moreover, the
EIS chip is sensitive enough to measure the micro-motion of a cell and therefore able to
monitor the progression of the cytotoxicity demonstrating the kinetic effects of the
nanoparticles on the cells. The results obtained from the EIS studies were compared to
the Sulforhodamine B colorimetric (SRB) assay commonly used for cytotoxicity
screening.
2.2 Experimental Details
2.2.1 Chemicals and reagents
Acetone, isopropyl alcohol (IPA), phosphate-buffered saline (PBS), sodium
phosphate (Na2HPO4), potassium dihydrogen phosphate (KH2PO4), potassium chloride
(KCl), sodium hydroxide (NaOH), hydrogen tetrachloroaurate (HAuCL4), trisodium
citrate (Na3C6H5O7), sodium borohydride (NaBH4), silver nitrate (AgNO3), sulfuric acid
(H2SO4) nitric acid (HNO3), trichloroacetic acid and acetic acid were all purchased from
Fisher. CdO and SWCNTs were purchased from Sigma Aldrich.

2.2.2 Nanomaterial selection and preparation
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The nanomaterials in this study—AuNPs, AgNPs and SWCNTs—were chosen
for the reason that they have attracted substantial research efforts for potential biomedical
and energy applications [11-15].
Synthesis of AuNPs - HAuCL4 (40 ml, 1.0 mM) was added to an Erlenmeyer flask (250
ml), stirred and brought to the boil on a hotplate. Na3C6H5O7 (4 ml, 1%) was added to the
boiling solution. Three minutes after the addition of Na3C6H5O7, 100 nm Au particles
formed. An additional 10 minutes of stirring produced 10 nm AuNPs. Phase imaging and
force spectroscopy were performed by AFM and TEM to characterize the nanoparticles.
Synthesis of AgNPs - NaBH4 (60 ml, 2 mM) was added to an Erlenmeyer flask (250 ml)
placed in an ice-bath and stirred. To this solution, AgNO3 (4 ml, 1.0 mM) solution was
added and stirred. Three minutes after the addition of AgNO3, 100 nm Ag particles were
formed and upon stirring for 30 more minutes, 10 nm Ag particles were formed. Phase
imaging and force spectroscopy were performed by AFM and TEM to characterize the
nanoparticles.
Preparation of SWCNTs - The SWCNTs were placed into a 3:1 mixture of 95% H2SO4 –
60% (HNO3). The solution was sonicated for 5 hours and following this the sample was
dried in an oven for 24 hours. Phase imaging and force spectroscopy were performed by
AFM and TEM to characterize the nanoparticles.

2.2.3 Cell culture
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CCL-153™ and RTgill-W1™ cells were purchased from American Type Culture
Collection (ATCC, Rockville, MD, USA) and were cultured in F-12K medium and
Leibovitz’s L-15 medium, respectively, with each of the media containing 10% fetal
bovine serum, 0.3 mg ml−1 L-glutamine, 100 U ml−1 penicillin and 100 mg ml−1
streptomycin. The cell cultures were placed in an incubator (37 ◦C, 5% CO2 atmosphere)
for 24 hours prior to the experiment so that the cells reached confluency with a final
concentration of 106 cells ml−1. 0.4 ml of cell suspension was inoculated into each well in
the EIS for the experiment.
2.2.4 EIS chip fabrication
Photolithographic technology was employed for the gold patterning of the
microelectrode array on the substrate. A mask defines the area of the chip that will be
exposed to UV light. The mask is placed on top of the photoresist during the exposure
process so that only the photoresist under the transparent part of the mask gets exposed.
Our fabrication procedure required two lithography masks, one for defining the pattern of
the gold electrode circuit and the other for defining the SU-8 isolating polymer layer. The
masks were made by sputtering a thin chromium layer on a 4’ × 4’ glass slide. A positive
photoresist (AZ1518) was spin coated on top of the thin chromium layer. Figure 2.1
illustrates the flow diagrams of the fabrication of the mask on the left and the
microelectrode array on the right.
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UV exposure lithography

Spin coat and Soft-bake of LOR

Photoresist Coating

Development
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Etching

Develop Photoresist and LOR

Remove the photoresist

Deposit gold film

Lift-off Bi-layer stack

Figure 2.1 - Flow diagram of fabrication of the mask (left) and the array chip (right).

Substrate cleaning and dehydration - To provide a conductive and transparent sidewall
for both electrochemical and optical monitoring, a clear microscope slide was used as the
substrate. The slide was cleaned with acetone, rinsed with deionized (DI) water and then
baked at 200 ◦C for 5 minutes on a contact hotplate.
Sacrifice layer coating - MicroChem’s LOR 3B was spin coated at 2500 rpm for 45
seconds followed by 10 minutes of baking on a hotplate at 150 ◦C. On top of the LOR
layer, AZ1518 positive photoresist was spin coated at 3500 rpm for 45 seconds and baked
in the oven at 110 ◦C for 6 minutes.
Exposure and development - After baking, the photoresist was exposed through a mask
under 12.5 mW cm−2 for 15 seconds (total dose is 187.5 mW cm−2). The slide was then
submerged in a 1:4 diluted AZ400K developer for 60 seconds for development.
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Deposition - 10 nm of Ti thin film was deposited with a growth rate of 3 nm per minute
at room temperature by a rf-magnetron sputtering system (AJA) using a Ti target. After
Ti deposition, a 150 nm (7 minutes) Au thin film was deposited on top of the Ti thin film.
Both the Ti and Au deposition was done in Ar ambient (10 sccm flow rate) at 75W of rf
power, 5 mTorr pressure and room temperature.
Lift-off - The slide was then submerged in MicroChem’s Remover PG and the sacrificial
layer was dissolved to form the desired pattern.
Protection layer coating - SU-8 was spin coated onto the slide at 2000 rpm for 45
seconds followed by 13 minutes of baking on a hotplate at 95 ◦C.
Final exposure and development - The photoresist was exposed through the mask under
12.5 mW cm−2 for 24 seconds (total dose is 300mW cm−2) and then baked on a hotplate
for 16 min at 95 ◦C. The substrate was finally dipped in SU-8 developer for 4 minutes,
and rinsed with IPA and DI water.
2.2.5 Electrochemical measurements
Cyclic voltammetric and differential pulse voltammetric measurements were
carried out using a CHI-630A electrochemical analyzer (CH Instruments, Inc., Austin,
TX, USA). The required redox solutions were freshly prepared every day before the start
of experiments. PBS (0.1 M) containing Na2HPO4 (50 mM), KH2PO4 (50 mM) and KCl
(100 mM) was adjusted to pH 7.2 by adding NaOH (0.1 M).
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2.2.6 AFM and TEM
Phase imaging and force spectroscopy were performed by using a Multimode
Nanoscope IIIa system from Veeco Instruments (Santa Barbara, CA, USA) in air with a
relative humidity 40–50% at room temperature.

A 200 keV transmission electron

microscope (Hitachi HF-2000 FEG) was used to analyze the structure and composition of
the nanomaterials. The TEM samples were dispersed in ethanol followed by sonication
for 15 minutes. The suspension was placed onto a copper grid covered with a carbon thin
film for analysis.
2.2.7 Sulforhodamine B (SRB) assay
The sulforhodamine B (SRB) assay was used for comparison of results by
measuring cell density based on the measurement of cellular protein content. SRB is
commonly used for toxicity screening of materials to adherent cells. CCL-153™ and
RTgill-W1™ were inoculated in a 12-well plate with a concentration of 106 cells ml−1 in
each well. After an incubation period of 48 hours, the cell monolayers were fixed with
10% (wt/vol) trichloroacetic acid and stained for 30 minutes, after which the excess dye
was removed by washing repeatedly with 1% (vol/vol) acetic acid. The protein-bound
dye was dissolved in 10 mM Tris base solution for optical density determination at 510
nm using a microplate reader.
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2.3. Results and Discussion
2.3.1 Impedance and resistance measurements using EIS chip
The EIS chip design (Figure 2.2) consists of an array of eight detecting gold
electrodes (250 µm in diameter) each on the bottom of individual tissue culture wells of
volume 9 × 9 × 10 mm3 to measure the change in impedance to AC current flow
(approximately 1 µA). A gold counter electrode (7 × 46 mm2) is linked to each individual
detecting electrode.
To provide a conductive and transparent sidewall for both electrochemical and
optical monitoring, a clear microscope slide (3” × 1.5” × 1.2 mm) was used as the
substrate, on top of which a 200 nm thick gold thin film was patterned by
photolithographic technology based upon the designed electrical circuit. Since the
sensing mechanism of the system is based upon the measurement of electrode surface
resistances, the electrode surface area plays an important role in the sensitivities. The
impedance of the circuit with a resistance (R) and a capacitor (C) in series can be
measured for each well by applying an alternating potential (AC) to the two electrodes
present in the EIS chip through a 1 MΩ resistor. Cells are placed in each well, drift
downward and attach themselves onto the electrode surface over time. The current
flowing though each electrode is now impeded by the cell monolayer, increasing the
impedance and resistance measurements. The smaller sized detecting electrode will
dominate the overall impedance in the circuit which will increase in just a few hours as
the cells gradually attach to the surface. From Ohm’s law, V = I R, it is possible to
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monitor the cell attachment and proliferation from the increase in impedance or resistance
measurements.

Figure 2.2 - Design of the electrical impedance sensing chip showing the array of eight detecting gold
electrodes. The cells attach on the electrode surface altering the measured resistance values

Using this system, nanotoxicity measurements can be made by monitoring the
change in resistance of each electrode. An extremely toxic material would cause the cells
to die and detach from the electrode at a rapid rate which, in turn, would decrease the
resistance reading of the system. On the other hand, a nontoxic material would not affect
the attachment of the cells; hence the resistance measurements would be similar to the
measurements of the cells by themselves (control).
An array design was chosen for the electrodes because of its potential to measure
multiple experimental designs simultaneously, allowing side by side comparison of the
various nanomaterials tested. This design also allows for relatively short measurement
times as the EIS is able to detect any interference in cell attachment within a few hours.
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2.3.2 Electrochemical characterization of the EIS chip
In order to successfully monitor cellular activity, we performed cyclic
voltammetry, one of the most widely used techniques for acquiring qualitative
information about electrochemical reactions, to test the reproducibility and sensitivity of
the EIS biosensor.

Electrochemical testing of the EIS biosensor is done to ensure

consistent and accurate readings for every experiment. In situ biosensor testing also
allows for rejection of biosensors which might have been damaged due to improper
storage or handling (e.g. at excessive temperatures) ensuring accurate data.
Quality electrochemical testing of the chips immediately before the measurements
will markedly increase the reliability of the chip’s performance. In situ chip testing not
only provides the possibility to correct minor chip fabrication errors, but also allows
rejection of chips which might have been damaged due to improper storage or handling
(e.g. at excessive temperatures). The electrochemical testing was carried out by running
cyclic voltammetry (CV) using a potassium ferricyanide (Fe CN



 

) redox probe.

CV is the most widely used technique for acquiring qualitative information about
electrochemical reactions. During the potential sweep, the potentiostat measures the
redox current resulting from the applied potential using the Randles–Sevcik equation
[16]:
𝑖𝑖 = 2.69  ×10   𝑛𝑛



   𝐴𝐴𝐴𝐴𝐷𝐷



   𝜐𝜐





where 𝑖𝑖 is the peak current, 𝑛𝑛 is the number of electrons, 𝐴𝐴 is the surface area of the

working electrode, 𝐶𝐶 is the bulk concentration of the electroactive species, 𝐷𝐷 is the
diffusion coefficient of the electroactive species and 𝜐𝜐 is the scan rate of voltammograms.
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The sensing electrode activity and the actual active electrode surface can be best
understood by carefully examining the current–concentration profiles during the potential
sweep. Four observables from the cyclic voltammetric response, the two peak currents
and two peak potentials, provide the basis for quality testing of the sensing electrodes.
The functionality of the EIS chip was measured by performing CV in Fe CN



 

(Figure 2.3). The gold microelectrodes designed in our laboratory exhibited reversibility
(ΔΕ = 64  mV) with a 6% attenuation in the observed peak current value after four

consecutive cycles showing high electrochemical activity and reproducible responses of
the redox probes.

1µA

-0.4

-0.2

0.0

0.2

0.4

E|V vs Ag|AgCl

Figure 2.3. Cyclic voltammogram of four electrodes on the fabricated EIS chip demonstrating the
reproducibility of electrochemical activities of the fabricated gold microelectrodes
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2.3.3 Nanomaterial characterization
In order to perform the nanotoxicity studies, we first fabricated and characterized
the nanomaterials using standard fabrication protocols and TEM imaging.

The

nanoparticles tested in this study, AuNPs (10, 100 nm), AgNPs (10, 100 nm) and
SWCNTs (cut, uncut), were all characterized using TEM and AFM (Figure 2.4). The
AuNPs and AgNPs were fabricated at different sizes (10 and 100 nm) and the SWCNTs
be purified in diluted acids to prevent unwanted contamination of impurities as specific
properties of the materials depend on their size and purity. The EIS was then used to
monitor the behavior of the nanomaterials in real-time over 40 hours on different 2D
living cell models (CCL-153, RTgill-W1) after exposure to the nanomaterials.

(a)

(b)

(c)

(d)

(e)

(f)

Figure 2.4. Transmission electron microscopy imaging of: (a) AuNPs (10 nm), (b) AgNPs (10 nm), (c) cut
SWCNTs, (d) SWCNTs, (e) raw SWCNTs and (f) purified SWCNTs.
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Nanomaterial characterization is necessary as specific properties of the materials
depend on their size and purity. The SWCNTs used in this study were purified in diluted
acids. Purified SWCNTs were tested to prevent unwanted contamination of impurities
such as amorphous carbon, graphite and catalyst metal particles which may reside on the
tubes. The AuNPs and AgNPs were fabricated at different sizes (10 and 100 nm) to
further understand the size effects of the particles and the underlying mechanisms that
govern the uptake of nanoparticles into cells. Most cell types undergo phagocytosis or
endocytosis to eliminate large particles that interact with the cell membrane; however, the
smaller sized particles may bypass the natural mechanical barriers of the cells which may
result in severe tissue damage [17].Once inside the cells, the nanoparticles may interfere
with the functions of the cell’s organelles and other biomolecular structures leading to
damage and even death of the cell. The exact mechanisms of this process are still not
fully understood [18-19]. However, with the EIS, the affects of the cellular uptake of the
nanoparticles on the proliferation of the cells will be demonstrated.
2.3.4 Cell exposure to cadmium oxide
CdO, which is extremely toxic, was employed to demonstrate the ability of the
EIS to measure kinetic effects of the nanoparticles before and after exposure to both
CCL-153 and RTgill-W1 cell lines. Cadmium is a toxic material that has been shown to
cause lysosomal damage and DNA breakage in mammalian cells and disrupt
mitochondrial function and promote apoptosis [20].
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In the first setup, the CdO was added to the wells along with the cells in the
beginning of the experimental run. This was done to observe the rapid toxic effects of the
CdO towards the cells. The resistance changes produced by the attachment of cells to the
electrodes were monitored over a 40 hour time period (Figures 2.5(a) and 2.6(a) green
lines (C lines)). Results indicated that upon inoculation of the CdO particles, a steady
resistance value was observed (similar to the resistance value of the blank) indicating
disruption in cell attachment. In the second setup, the cells were allowed to grow on the
electrode to confluency over a period of 20 hour before the CdO was added. This setup
would provide the kinetics of the interaction of CdO with the cells. Once the CdO was
added to the cells, we observed a rapid decrease in the resistance values measured,
eventually returning to readings similar to the blank, indicating cell detachment and the
harsh cytotoxic effect of CdO towards both CCL-153 and RTgill-W1 (Figures 2.5(a) and
2.6(a) blue lines (D lines)). These results demonstrate the capability of the EIS to monitor
cytotoxicity instantaneously and continuously.
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Figure 2.5 - Resistance readings for CdO (a), Au (b), Ag (c) and SWCNT (d) on CCL-153. Lines A and B
in all graphs represent the Blank and the Control (cells only) resistance readings. In (a), CdO is added
initially (line C) and after 20 hours of cell attachment (line D). In (b), lines C and D represent AuNPS sized
10 nm and 100 nm respectively. In (c), lines C and D represent AgNPS sized 10 nm and 100 nm
respectively, and in (d), lines C and D represent the cut and uncut SWCNTs respectively
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Figure 2.6. Resistance readings for CdO (a), Au (b), Ag (c) and SWCNT (d) on RTgill-W1. Lines A and B
in all graphs represent the Blank and the Control (cells only) resistance readings. In (a), CdO is added
initially (line C) and after 20 hours of cell attachment (line D). In (b), lines C and D represent AuNPS sized
10 nm and 100 nm respectively. In (c), lines C and D represent AgNPS sized 10 nm and 100 nm
respectively, and in (d), lines C and D represent the cut and uncut SWCNTs respectively.

2.3.5 Cell exposure to gold and silver nanoparticles
AuNPs have been reported to exhibit inert properties, as previous studies have
shown that AuNPs with a size less than 100 nm did not induce any adverse effects in
human cells [18-19]. Due to these inert properties, AuNPs are often employed in research
for various applications such as gene and drug delivery transfection vectors, DNAbinding agents and in various imaging systems [5].
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The cytotoxic measurements of AuNPs (10, 100 nm) towards CCL-153 and
RTgill-W1 over a 40 hour time period showed little difference in resistance values to
those observed for the control (Figures 2.5(b) and 2.6(b) green and blue lines (C and D
lines) respectively). From this observation, it is evident that AuNPs have few cytotoxic
effects on both the CCL-153 and the RTgill-W1.
In contrast, Ag has been shown to exhibit a strong toxicity to a wide range of
micro-organisms and is widely used in antibacterial solutions [21], and when eukaryotic
cells are exposed to Ag nanoparticles an apoptotic effect is noticed [22]. When CCL-153
and RTgill-W1 cells were both exposed to AgNPs (10, 100 nm) noticeable changes in
resistance were observed. The measurements for the 100 nm AgNPs exhibited overall
lower resistance values compared to the control, indicating a slower attachment rate of
the cells (Figures 2.5(c) and 2.6(c) green lines (C lines)). However, for the 10 nm sized
particles, the resistance changes were very small, almost negligible, showing a stronger
cytotoxicity for the smaller particles (Figures 2.5(c) and 2.6(c) blue lines (D lines)). The
observed phenomena may be attributed to the fact that the smaller AgNPs can enter the
cell easily and possibly interfere with the cellular mechanism thereby decreasing the cell
attachment and thus lowering the resistance values.
2.3.6 Cell exposure to SWCNTs
Rapid advancements in SWCNTs research call for a clearer picture of their
cytotoxicity as the effects of SWCNT surface chemistry, surface area and aggregation on
the cell cycle is not well established [20]. Further, the length of the SWCNTs is an
important factor to consider, as it is evident from previous works that ultra-short
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SWCNTs can be used as reinforcing agents to enhance the mechanical properties of
certain polymers in various biomedical applications [23]. Shorter SWCNTs may affect
the cells in a different manner than their longer counterparts as they may enter and
damage the cells more easily.
We have thus evaluated the cytotoxic effect of SWCNTs (cut and uncut) on CCL153 and RTgill-W1 cells by monitoring the resistance values over 40 h. Results indicated
that the SWCNTs (cut and uncut) exhibited a similar decrease in the resistance value to
the control (Figures 2.5(d) and 2.6(d) green and blue lines (C and D lines) respectively).
From this, it is evident that SWCNTs affected the growth mechanism of the CCL-153
and RTgill-W1.
2.3.7. Sulforhodamine B (SRB) assay
The optical density values obtained from the SRB assay correlate with total
protein content and therefore with cell number. Table 2.1 lists the values obtained for the
SRB assays with CdO, AuNPs, AgNPs and SWCNTs.
Optical Density
Control

2.7

CdO

0.6

AuNPs (10 nm)

2.5

AuNPs (100 nm)

2.6

AgNPs (10 nm)

1.3

AuNPs (100 nm)

1.6

SWCNTs (cut)

2.2

SWCNTs (uncut)

2.1

	
  

Table 2.1 - Optical density values obtained from the SRB assay on CCL-153.
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2.4 Conclusion
With the increasing number of nanomaterial applications, assessing their toxicity
should be the first important step toward creating safety guidelines for their handling and
disposal. In this work, we have successfully designed an EIS chip and evaluated its
suitability for various cytotoxicity measurements by electrochemical experiments.
Results indicated that the EIS chip exhibited a stable and reproducible response when
measuring the effects of various nanomaterials—AuNPs (10, 100 nm), AgNPs (10, 100
nm), SWCNTs (cut, uncut) and CdO—towards CCL-153 and RTgill-W1 cells. Moreover,
the EIS chip was sensitive enough to measure the micro-motion of a cell and therefore
was able to monitor the progression of the cytotoxicity demonstrating the kinetic effects
of the nanoparticles on the cells. Further, the EIS chip allowed rapid, real-time and multisample analysis creating a versatile, noninvasive tool that is able to provide quantitative
information with respect to alteration in cellular function under various nanomaterial
exposures.
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Chapter 3

IMPEDANCE BASED NANOTOXICITY ASSESSMENT OF GRAPHENE
NANOMATERIALS AT THE CELLULAR AND TISSUE LEVEL

This chapter was submitted as follows (with slight modifications): Hondroulis, E.,
Zhang, Z., Li, C.Z. (2012) Impedance based Nanotoxicity Assessment of Graphene
Nanomaterials at the Cellular and Tissue Level. Analytical Letters 45, 2-3.
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3.1 Introduction
After successfully demonstrating the EIS’ capability of monitoring the behavior
of 2D cell cultures in real-time when exposed to various nanomaterials, we took the
nanotoxicity study one step further by analyzing the effects of graphene on a novel 3D
tissue model and its individual components. The interest in graphene for biomedical
applications has grown substantially in the past few years creating a need for
biocompatibility testing. Biomedical engineering applications using graphene such as
biosensing devices, microbial detection, disease diagnosis and drug delivery systems are
progressing rapidly, perhaps overlooking any possible hazards as graphene nanomaterials
may interact with biological materials differently than other graphitic materials such as
carbon nanotubes and fullerenes.
Graphene’s structure is simple, single-atom–thick sheets of carbon; however, its
potential in the scientific world has been intense. Due to its unique features, researchers
have rushed to study its many potential applications such as Nanoelectronic devices,
transparent conductors, and nanocomposites [1-2], while possibly overlooking any
potential hazards. The cytotoxic effects of other carbon nanomaterials such as fullerenes,
nanotubes, and nanofibers have been studied before with mixed results [3-4].

The

general consensus for the cause of cytotoxicity of these materials seems to be due to their
byproducts or residues such as metal traces and amorphous carbon which cause oxidative
stress to the cells [5-7]. The cytotoxic effects of graphene may be different than those of
other graphitic materials as cytotoxicity studies on graphene are far and few between.
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Biomedical engineering applications using graphene have surfaced recently in the
form of biosensing devices [8-9], enzymatic biofuel cells [10], microbial detection,
disease diagnosis, and drug delivery systems [11], creating a cell-graphene interface that
must be explored further. Although similar in chemical composition, graphene compared
to its carbon counterparts may behave differently when interacting with biological
elements as it lacks the transition metals, Fe, Ni, and so forth, which are present with
carbon nanotubes, for example, leading to its high purity [12]. It has been shown that
cells could grow on graphene sheets [13]; however, one must still examine the cellular
interaction of graphene as a nanomaterial as the graphene’s properties may change and
may produce certain threats to the biological systems that its bulk counterpart may not.
One major potential application of carbon based nanomaterials is for drug
delivery. The use of nanomaterials for targeted drug delivery is becoming a popular topic
of interest in the field of biomedical engineering with many recent advances. For
instance, Z. Liu et al. [14] recently tested single walled carbon nanotubes as carriers for
the drug paclitaxel to target tumors in mice and showed higher ratios of tumor to normal
organ uptake of the drug-carbon nanotube combination. Using nanomaterials to transport
the desired drug prevents unwanted side effects since the drug is targeted only in the
desired site, and can minimize drug dilution throughout the body increasing the drug
concentration delivered to the pathological area [15]. Graphene and graphene oxide with
their unique properties are on the forefront of this technology [16].
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One area of interest in particular to drug delivery is the blood brain barrier (BBB),
a tight seal of endothelial cells that lines the blood vessels in the brain that selectively
allows the entry of certain molecules from blood circulation into the brain. Maintaining
the integrity of the BBB is an important issue when designing a drug delivery system and
thus the interaction of these graphene nanomaterials with the BBB must be explored
further. Recently, Z. Zhang et al. [17] created an in vitro BBB model consisting of
immortalized rat astrocytes and mouse brain endothelial cells as the building blocks and a
novel astrocyte derived acellular extracellular matrix (aECM) as the biomimetic
basement membrane for the endothelial cells. This model proved successful in testing the
transport rate of doxorubicin through the BBB while maintaining the integrity of the
structure. In this study, the cytotoxicity of graphene nanomaterials was measured on this
in vitro model by measuring the Trans Endothelial-Electrical Resistance (TEER) values
of the tissue before and after exposure to the graphene.
Biosensors for real-time monitoring of cellular activity when subjected to various
compounds such as nanoparticles has been the focus of this dissertation since
conventional biological methods for measurement of cytotoxicity measure toxicity at a
final time point. To obtain the kinetic model of the graphene uptake in the individual cells
of the BBB, it is also necessary to test the cytotoxicity of the individual components of
the BBB, rat astrocytes (CRL-2006) and mouse endothelial cells (CRL-2583) using the
EIS [18-19].
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3.2 Experimental Details
3.2.1 Chemicals and reagents
Phenol

red-free

0.25%Trypsin/EDTA,

Dulbecco’s

Modified

Eagle’s

Penicillin-Streptomycin-Glutamine,

Medium

(DMEM),

Dulbecco’s

phosphate

buffered saline (PBS), and distilled water were purchased from Invitrogen (Carlsbad,
CA). Fetal bovine serum was purchased from Hyclone (Logan, UT). Mouse endothelial
cells from yolk sac and rat astrocyte from 1-day old rats were purchased from American
Type Culture Collection (ATCC) (Manassas, VA). Graphite and hydrazine hydrate were
purchased from Sigma.
3.2.2 Synthesis of graphene
The graphene was synthesized in the following manner. Graphitic oxide (GO)
was prepared from graphite powder as described by Hummers and Offeman (1958) [20]
then was then mixed with water to yield a yellow-brown suspension. The suspension was
then ultrasonicated until the solution was free of any particulates, was treated with
hydrazine hydrate, and then heated in an oil bath at about 100 °C in a water cooled
condenser for about 24 hours. The reduced GO gradually precipitated as a black solid
which was then ﬁltered and washed with deionized water (5 × 100 mL) and methanol (5
× 100 mL) then dried using continuous N2 ﬂow for about 10 hours [9]. Figure 3.1 is a
scanning electron microscope (SEM) image of the graphene produced.
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Figure 3.1 - SEM image of graphene

3.2.3 Cell Culture
CRL-2006™ and CRL-2583™ cells were purchased from American Type Culture
Collection (ATCC, Rockville, MD, USA) and were cultured in DMEM supplemented
with 10% FBS and 1% Penicillin/Streptomycin. The cell cultures were placed in an
incubator (37 ◦C, 5% CO2 atmosphere) for 24 hours prior to the experiment so that the
cells reached confluency with a final concentration of 105 cells ml−1.
3.2.4 In vitro BBB models
The in vitro BBB model was designed with three layers: confluent mouse
endothelial cells, aECM and confluent rat astrocytes grown on opposite sides of COL
Transwell inserts for 24-well plates. As a control, the aECM was removed from some of
the inserts to ensure the purpose of the aECM to closely mimic the in vivo BBB. Figure
3.2 shows a schematic of the setup to create the in vitro BBB model with and without the
aECM.
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Figure 3.2 - Schematic of the setup for the in vitro BBB model showing the three layers: confluent mouse
endothelial cells, aECM, and confluent rat astrocytes grown on opposite sides of COL Transwell inserts for
24-well plates and the control model without the aECM

3.2.5 Detection of Tight Junction Protein Occludin	
  
One main aspect of the BBB that needs to be considered when creating an in vitro
model is the formation of tight junctions that occur in vivo. To ensure that our model had
the required tight junction formations, immuno-fluorescence microscopy was done on our
BBB model with the aECM layer and the control model without to observe the
expression of occludin, a plasma-membrane protein located specifically at the tight
junctions. Figure 3.3 shows the immuno-fluorescence microscopy on the BBB model
without the aECM (A) and with the aECM (B) layer. Occludin's contours could be
observed in both sample setups, however, they were more abundant in the model with the
aECM. The details can be found elsewhere [17].
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Figure 3.3 - Immuno-fluorescence microscopy on the BBB model without the aECM (A) and with the
aECM (B) layer. The arrows both figures indicate the tight junctions formed.

3.2.6 Trans Endothelial-Electrical Resistance (TEER) Measurement
TEER values were measured for the in vitro BBB model before and after
exposure to graphene for three consecutive days using EVOM® epithelial voltohmmeter
with EndOhm tissue resistance measurement chambers especially designed for tissue
culture inserts (World Precision Instruments, Sarasota, FL). The TEER values were
calculated by taking the meter reading and multiplying by the surface area of the
individual chamber. The final values were recorded in units of Ωcm2.
3.2.7 Resistance Measurements Using EIS chip
The purpose of the design of the EIS chip is to allow continuous monitoring of
cellular behavior, thus the design must incorporate culture wells for the cells to grow.
Through photolithographic technology, the EIS chip was designed with an array of eight
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detecting gold electrodes (250 µm in diameter) each on the bottom of individual tissue
culture wells of volume 9 × 9 × 10 mm3 that measure the change in impedance to AC
current flow (approximately 1 µA). Cells are placed in each well and as they gradually
attach themselves to the surface of the electrode, the current though each electrode is now
impeded by the cell monolayer, increasing the impedance and resistance measurements.
The details can be found elsewhere [18]. 0.4 ml of cell suspension was inoculated into
each well in the EIS chip for the experiments.
3.3 Results and Discussion
With the increasing number of cytotoxicity studies on carbon based materials
such as carbon nanotubes [21-22] and fullerenes [23-24] attention needs to be focused on
the 2D counterpart graphene. Very few studies have been done on graphene toxicity;
however, the results look promising.

Graphene paper has been shown to be

biocompatible because L929 cells were successfully cultivated on it [25], and graphene
oxide has been used to create glucose biosensors with good biocompatibility [1].
However, once in nanoparticle form, the size and shape of the graphene can change the
interaction of the graphene and the biological material.
3.3.1 BBB Tissue Toxicity
In the first experiment, the integrity of the in vitro model of the BBB after
exposure to graphene nanomaterials was tested. Trans-Endothelial Electrical Resistance
(TEER) values were taken for the empty COL Transwell inserts (blank), the in vitro BBB
model (control), the model with graphene nanomaterials, and the model with cadmium
oxide (CdO) as a negative control. The TEER values show the confluence of a cell
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monolayer with the increase in resistance values. Figure 3.4 is a graph of the TEER
measurements taken each day over a timeframe of three days. The results indicate that the
TEER values of the in vitro BBB model after exposure to graphene nanomaterials
remained similar to the TEER values of the model control, each increasing as the
monolayers start to form. The TEER values of the model incorporated with CdO
demonstrated a sharp decrease as expected since cadmium is a known toxin that has been
shown to cause lysosomal damage, DNA breakage, disruption of mitochondrial function,
and promotion of apoptosis in mammalian cells [26]. With the graphene present, the
integrity of the in vitro BBB model remained strong thus showing the low cytotoxicity of
graphene toward the tissue model.
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Figure 3.4 - Trans-Endothelial Electrical Resistance (TEER) values taken for the empty COL Transwell
inserts (blank), the in vitro BBB model (control), the model with graphene nanomaterials, and the model
with cadmium oxide (CdO) as a negative control. The resistance values of the in vitro model should
increase as the days progress due to the growth of the cells in the insert. The results show consistent
resistance values in both the control and the graphene samples over a three day timeframe and a decrease in
resistance values for the CdO
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3.3.2 BBB Cellular Component Toxicity
On the cellular level, the EIS chip was used to detect cytotoxicity of astrocytes
and endothelial cell monolayers by monitoring the change in resistance of each electrode
with the cells in place. A typical cell attachment curve would have a continuous increase
in resistance at a rate depending on the proliferation rate of the type of cells studied. If an
extremely toxic material were added to the sample, such as CdO, there would be a
decrease in the resistance values compared to the control as the cells would be damaged
and eventually detach from the electrode. This can be seen in the resistance values of
both the CRL-2006 and the CRL-2583 when exposed to the negative control CdO seen in
Figures 3.5 and 3.6, respectively. With both cell types, the resistance levels remained at a
fairly constant level indicating very low cell attachment and thus cell death.
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Figure 3.5 - Resistance measurements for rat astrocytes CRL-2006 over 20 hours. The solid line and the
dashed line represent the resistance measurements for the astrocytes and the astrocytes with graphene
nanomaterials respectively. The resistance measurements are very similar indicating low cytotoxicity of
graphene toward the astrocytes as compared to the CdO resistance values which remain low indicating low
cell attachment
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Figure 3.6 - Resistance measurements for mouse endothelial cells CRL-2583 over 20 hours. The solid line
and the dashed line represent the resistance measurements for the endothelial cells and the endothelial cells
with graphene nanomaterials respectively. The resistance measurements are very similar indicating low
cytotoxicity of graphene toward the endothelial cells as compared to the CdO resistance values which
remain low indicating low cell attachment

On the contrary, a nontoxic material would not affect the attachment of the cells
leading to similar resistance measurements to the cells alone (control). For example, gold
was previously tested using this biosensing chip on human lung fibroblasts [18] as gold
has been shown to have inert properties toward biological materials and has been widely
used in biomedical engineering applications [27]. The resistance values measured after
the gold was incorporated with the cells showed little difference compared to the control.
Our results for the graphene are similar to those of the gold such that after 20 hours of
exposure to graphene, neither the CRL-2006 nor the CRL-2583 were affected as seen in
the small difference in resistance values to those observed for the control. From this
observation, it is evident that the graphene has little cytotoxic effects on both the cell
types.
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A possible explanation of this low cytotoxicity could be that graphene, when
produced, is a highly pure material lacking the common residual elements seen in other
carbon materials such as carbon nanotubes. These residuals, such as Fe, Ni, Co, and Mo,
even after washing mechanisms seem to remain attached to the nanotubes, a possible
result of the nanotubes shape [28]. Pulskamp, Diabate´ and Krug (2007) [7] recently
showed that carbon nanotubes with the residuals still attached produced an increase in the
formation of the reactive oxygen species (ROS) commonly produced by cells under stress
compared to more purified carbon nanotubes.
3.4 Conclusion
With the increasing number of graphene based biomedical applications, assessing
the cytotoxicity is an important first step toward ensuring biocompatibility. In this work,
we have successfully demonstrated the low toxicity of graphene nanomaterials on an in
vitro BBB model and its individual components, astrocytes, and endothelial cells, using
resistance measurements in the forms of TEER and an EIS chip designed to capture the
real-time effects of the graphene. The graphene nanomaterials showed little toxicity
toward both the tissue model and the cellular components providing proof for graphene’s
potential as a successful vehicle for drug delivery applications.
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Chapter 4

ELECTRICAL FIELD MANIPULATION OF CANCER CELL BEHAVIOR
MONITORED BY WHOLE CELL BIOSENSING DEVICE

This chapter was submitted as follows (with slight modifications): Hondroulis, E.,
Melnick, S.J., Wu, Z.Z., Zhang, X., Li, C.Z. (2013) Electrical field manipulation of
cancer cell behavior monitored by whole cell biosensing device, Biomedical
Microdevices, 15, 657-663.
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4.1 Introduction
After successfully showing the EIS’ capability of monitoring cell behavior
through the nanotoxicity studies, our interest in cell electronics led us to further maximize
the EIS’ potential. By using electrical signals, biosensors can provide direct, real–time
monitoring of biological processes, and in turn, local electric fields generated by the
devices can influence biological processes. This integration of cells and electronic
devices ultimately led us to investigate the effects of electric fields on cell behavior.
Electrically directed and coordinated cell movement plays a significant role in
mammalian cell behavior starting from embryonic development.

The effects of

exogenous electric fields on physiology and their possible relationship to diseases have
interested researchers for years [1-3]. The use of electric fields has become popular in
fields such as gene and cellular therapies [4-6], and has even progressed to clinical trials
for drug delivery [7], however; still little is known how electric fields may interact with
intracellular signaling pathways to potentially alter cell physiology.
Living cells are associated with electrical characteristics due to the cell membrane
transport processes and are thus responsive to and even generate electric fields and
currents. Cells control the exchange of electrically charged ions across their membrane
creating a membrane potential with different amounts of electrical charges inside and
outside the cell. A shift in membrane potential will alter the exchange of ions across it
and vice versa. For instance, it has been shown that alteration in membrane potential can
alter the signal pathways involved in mitosis of the cell and thus its proliferation [8].
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Recently, there has been interest in the therapeutic use of alternating electric
fields as a treatment for cancer. Since the electrical and physical properties of cancer
cells differ from normal proliferating cells, electric fields may induce differential effects
in normal and cancer cells. For example, cancer cells exhibit a lower membrane electrical
potential compared to normal cells. Cancer cells also exhibit disorganized growth, weak
interactions with their neighboring cells and do not exhibit contact inhibition of their
growth [9]. Consequently further research is warranted to establish the role of electric
field therapy for the treatment of cancer.
According to the National Cancer Institute each year more than 22,000 women in
the United States develop ovarian cancer and because of this, we decided to use the EIS
[11-12] to monitor the effects of external alternating electric fields on the behavior of
ovarian cancer cells HTB-77™ (SKOV3) compared to normal human umbilical vascular
endothelial cells CRL-1730™ (HUVEC). The electric fields tested are within a range of
frequencies (50 kHz- 2 MHz) and at low-intensity (<2 V/cm). Electric fields with these
properties have been shown to inhibit growth in vivo [13] in support of this line of
research. The EIS will measure in real-time the electrode surface impedance changes
produced by growing cell monolayers over the electrodes and detecting any changes in
resistance associated with changes in the cell layer after electric field exposure to
determine the greatest degree of growth inhibition for these types of cancer cell lines.
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4.2 Experimental Details
4.2.1. Cell culture
HTB-77™ and CRL-1730™ cells were purchased from American Type Culture
Collection (ATCC, Rockville, MD, USA) and were cultured in McCoy’s 5A Modified
Medium and Dulbecco’s Modified Eagle Medium respectively, each containing 10%
fetal bovine serum, 0.3 mg ml−1 L-glutamine, 100 U ml−1 penicillin and 100 mg ml−1
streptomycin. The cell cultures were placed in an incubator (37 ◦C, 5% CO2 atmosphere)
for 24 hours prior to the experiment so that the cells reached confluency with a final
concentration of 105 cells ml−1. 0.4 ml of cell suspension was inoculated into each well
in the EIS chip for the experiments.
4.2.2 Electrical impedance sensing (EIS)
The EIS chip design was previously reported [11]. In short, individual tissue
culture wells of volume 9 × 9 × 10 mm3 are placed over an array of eight detecting gold
electrodes (250 µm in diameter) each linked to a gold counter electrode (7 × 46 mm2).
4.2.3 Application of external electric field
To incorporate the external electric field to the EIS chip, a unique system of a pair
of insulated wires (BLK KYNAR 100’, conductor area 0.25 mm) was designed to be
placed in conjunction with the 8 well array design of the EIS chip. The wires were
placed in 4 of the wells with the other 4 wells used as the control. The wires were placed
1mm apart to allow spacing to encompass the whole electrode area. Figure 4.1 shows a
schematic of the wire setup and the resulting electric field surrounding the electrodes. A
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Leader LFG-1300S Function Generator was used to provide the square AC waves at the
desired frequencies.

Figure 4.1 - Schematic of wire setup for application of external alternating electric fields to the EIS chip.
The two wires (black lines) were spaced at approximately 1 mm apart to encompass the entire electrode
(gold circles) on the EIS chip. The red lines represent the resulting electric field generated

4.2.4 Immunofluorescence Staining
Propidium iodide (PI) was purchased from Calbiochem (San Diego, CA) and
diluted to 50 µg/ml with DI water. 105 cells/ml were added to standard petri dishes, one
with wires placed on the bottom spaced 1 mm apart to apply an external electric field of
200 kHz and one without wires as the control. 25 µl of PI was added to each dish and
incubated in the dark for 10 minutes. Fluorescence intensity was determined using a
confocal microscope (Perkin Elmer UltraView Vox system, USA). With an excitation
wave length of 530 nm and an emission filter of 620 nm. PI attaches to the DNA of the
cell, and thus cells with broken membranes will be targeted.
4.2.5 Cell Viability Assay
Trypan blue was purchased from Sigma Aldrich. 105 cells/ml were added to
standard petri dishes, one with wires placed on the bottom spaced 1 mm apart to apply an
external electric field of 200 kHz and one without wires as the control. After 40 hours,
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the cells were removed with 0.25% trypsin/EDTA (GIBCO), alloquotted into centrifuge
tubes and were spun for 5 minutes at 100 x g. The supernatant was discarded and the
cells were resuspended with 1 ml PBS (Fisher Scientific). A 1:1 ratio of 0.4% Trypan
Blue and cell suspension was made and was allowed to sit for 3 minutes for the cells to
incorporate the dye. 20 µl of the cell suspension was then added to a hemocytometer to
perform a cell count. The % viability was calculated using the following equation:
viable cells (%) = total number of viable cells per ml of aliquot
total number of cells per ml of aliquot

x 100

4.3 Results
4.3.1 Optimal Frequency
Five frequencies of alternating electric fields that sample a broad radiofrequency
range, 50, 100, 150 and 200 kHz and 2 MHz, were tested on both SKOV3 and HUVEC
to find the optimal frequency that would most hinder the growth of the SKOV3 cells
without harming the normal HUVECs.

Intermediate frequencies of around 100 kHz

have previously been reported to not have any detrimental effects on cells [14], however,
according to Kirson et. al. [13], specific types of cancer cells may behave differently
under the range of 100 kHz to 1 MHz frequencies with the theory that the electric fields
disrupt the normal mitotic process of proliferating cells. The choice of frequencies is in
part based on this study. Frequencies in the lower (50 kHz) and higher (2MHz) range
were also included.
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Using the EIS biosensor, we monitored the proliferation rate of the cells under the
influence of the alternating electric fields in real-time by analyzing the change in
resistance values of the detecting electrodes.

Proliferating cells will gradually attach

and spread across the electrode surface creating an increase in resistance values. Any
change in proliferation is detected by a decrease the resistance values. Figures 4.2 (a)
and (b) show the resistance values obtained from the HUVECs and the SKOV3
respectively in the target range under 100, 150 and 200 kHz applied at the start of the run
compared to the cells alone, both over a timeframe of 40 hours. The EIS biosensor was
able to detect no noticeable difference in the resistance values when the alternating
electric field was applied to the HUVECs compared to the control, thus indicating no
obvious effect of the electric fields of the three frequencies on the HUVECs proliferation.
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Figure 4.2. Resistance values of HUVECs (a) and SKOV3 (b) under electric fields of frequencies 100, 150
and 200 kHz. No apparent effect was noticed for the normal HUVECs, however, a significant decrease in
resistance values was observed for the SKOV3 for all three frequencies. For further comparison, 50 kHz
(c) and 2 MHz (d) frequencies were tested on SKOV3 and showed no apparent effect on the cell
proliferation as seen in the similar resistance curves to the control. 200 kHz showed the largest decrease
out of all the frequencies

In contrast, the SKOV3 had lower resistance values compared to the control with
200 kHz providing the lowest resistance values out of the three frequencies. These
results indicate that the growth and proliferation rate of the SKOV3 was hindered by the
alternating electric field at each frequency evaluated with 200 kHz being the most
effective frequency. The resistance values still increased over time with the applied
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external electric fields; however, the overall values were lower than the control. This
difference can be attributed to a slower rate of proliferation and attachment of the cells to
the electrodes and thus showing growth inhibition. For justification that this range of
frequencies is optimal for disrupting the SKOV3 cell proliferation, 50 kHz and 2 MHz
frequencies were tested as well on the SKOV3 and were compared with the results from
200 kHz (Figures 4.2 (c), (d) respectively). Neither 50 kHz nor 2 MHz affected the
SKOV3 proliferation compared to the 200 kHz frequency, and thus we focused more
closely on this frequency.
4.3.2 Focus on 200 kHz
In the subsequent experiment, the 200 kHz field was applied to the cells after they
reached confluency on the EIS electrodes. This was done to determine whether the field
affected the cells before or after attachment. Most cell types need to attach to a substrate
in order to proliferate, however, it has been shown that cancer cells have a lower
tendency for adhesion which in turn could lead to metastasis [15]. The SKOV3 were
placed in the wells with the wires in place at the beginning of the run without applying
the external electric field. The resistance changes produced by the attachment of cells to
the electrodes were monitored for 40 hours, allowing the cells to reach confluency, and
then the 200 kHz field was applied. With the addition of the field, there was a noticeable
decrease in resistance values over time indicating disruption of cell attachment to the
electrodes (Figure 4.3 (a)).
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In addition to the measurement of resistance, the effects of the alternating electric
fields on the SKOV3 cells were evaluated by examining digital images taken of the
detecting electrodes; the electrode with SKOV3 cells after 40 hours once they reached
confluency the electrode after 1 hour of 200 kHz applied field to the confluent cells and
the electrode after another 40 hours of exposure to the electric field (Figure 4.3 (b), (c),
(d) respectively). Prior to the application of the alternating electric field, the image of the
electrode shows a confluent monolayer of cells covering it as is expected without any
external stimulus. Normal proliferating cells attached to a substrate will have a flattened
morphology as they extend themselves along the surface as shown in Figure 3b.
However, once the 200 kHz electric field was applied, the cell morphology changed to a
more round shape even after only an hour of exposure to the field, indicating a disruption
in the attachment of the cells to the electrode. Finally, after 40 hours of exposure to the
electric field, the cell number diminished significantly indicating a disruption in the cell
proliferation.
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Figure 4.3 - Resistance values of SKOV3 cells when subjected to 200 kHz electric field after 40 hours on
the electrode (a). Digital images were taken of this electrode to visualize the cell attachment process.
Figure 4b shows the electrode after the cells reached confluency over the electrode. After this, the 200 kHz
field was applied and within an hour another image was taken (c). The cells have changed morphology to a
more rounded shape compared to the initial image. After an additional 40 hours of exposure to the electric
field, another image was taken (d) which shows a significant decrease in cell number on the electrode

4.3.3 Immunofluorecence Staining and Cell Viability Assay
Two additional methods for measuring cell viability after exposure to the
alternating electric fields were performed to independently correlate the results obtained
by the EIS. Immunofluorecence images were taken using PI, a fluorescent molecule that
binds to the DNA of cells. Since PI is impermeable to cell membranes, viable cells will
not incorporate the molecule and thus it can be used for cell viability assays. Figures 4.4
(a) and (b) show the fluorescence images of the SKOV3 without and with the 200 kHz
field after 40 hours of exposure respectively. The cells that were subjected to the field
showed more fluorescence than the control indicating a higher occurrence of cell death.
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Trypan Blue exclusion test for cell viability was also performed. Trypan Blue is a dye
that cannot penetrate the intact cell membranes of viable cells, thus indicating the total
amount of viable cell in a sample. Figure 4.4 (c) is a chart showing the percent viability
estimated by the number of attached SKOV3 after exposure to the alternating electric
fields in the target range of 100, 150 and 200 kHz.

Similar to the EIS data, after

exposure to 200 kHz, the cells exhibited the least amount of cell viability.
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Figure 4.4 - Fluorescence imaging using propiduim iodide (PI). SKOV3 cells were grown on petri dish,
one control (a) with no external electric field and one with wires providing 200 kHz frequency (b). After 40
hours, the cells were stained with PI and the cells exposed to 200 kHz showed significant cell death as seen
in the increase in fluorescence compared to the control. To further justify the effects of the 200 kHz
electric field on SKOV3, Trypan Blue exclusion test for cell viability was performed for 100, 150 and 200
kHz (c). 200 kHz showed the lowest percent viability of 58%
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4.4 Discussion
Research on the effects of alternating electric fields on biological samples has
been a growing interest for biomedical researchers over the years. Cells have intrinsic
electrical properties that are implicit to metabolism and other cellular functions. Many of
the electrical properties are derived from the cellular membrane consisting of a lipid
bilayer embedded with various transmembrane proteins creating ionic channels that
comprise the cell’s transmembrane potential. Evidence suggests that cellular properties
such as proliferation, adhesion, differentiation, morphology and migration, and function
are influenced by external alternation electric fields suggesting a relationship between
these properties and the electrical properties of cells. A deeper understanding of this
relationship will yield a more comprehensive view of cell function and the role that
electric field therapies may play in the treatment of diseases such as cancer.
Cancer cells have been shown to have different membrane properties than regular
cells. One property that may play a large role in cancer behavior is the membrane
fluidity since cancer cells seem to have higher membrane fluidity than non-cancer cells.
Increased membrane fluidity also affect the cell’s motility and deformation [16] leading
to a hindered cell–matrix adhesion and ultimately specific cell responses that influence
cell adhesion, motility, shape, orientation, differentiation, and survival. Cells that are
attached and thus capable of proliferating have a flattened appearance due to cell
spreading. As we have shown, once subjected to the field, the SKOV3 cells changed
morphology within only an hour of exposure to the 200 kHz applied field.
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The cells

acquired a more round shape which could be attributed to the increase in membrane
fluidity of the cells under the electric field.
Another important feature for cell survival is the membrane potential. Cancer
cells also exhibit an increase in negative surface charge of their membrane [17] compared
to normal cells and thus have cell membrane potentials that are lower than the cell
membrane potential of healthy cells. When subjected to external electric fields, the
membrane experiences most of the potential drop in the cell leading to conformational
changes in proteins and enzymes embedded within the membrane ultimately affecting the
cell’s capability for proliferation and differentiation [18]. For example, biochemical and
physiological changes occur when weak electric currents are applied to a cell due to a
change in transmembrane potential induced on the cell membrane. Since the membrane is
flexible, permeation of the cell membrane occurs leading to a higher exchange of
materials across the membrane, a process known as electroporation [19]. This process
has been widely used in biomedical research in areas such as drug delivery [20-21] and
gene transfer [22] because of its reversibility. In this study, we show that a low intensity
electric field at 200 kHz has a detrimental effect on cancerous SKOV3 cells without
affecting the non-cancerous HUVEC cells.
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4.5 Conclusion
Many current treatments for cancer are effective; however, a major limitation in
these treatments is their toxicities and side effects. Electric field therapies as an adjuvant
for cancer treatment show considerable promise; however, further preclinical and clinical
investigation is required. The outcome of this research will improve our fundamental
understanding of the behavior of cancer cells to alternating electric fields and define a
strategy and optimal parameters of electrotherapy for clinical and drug delivery
applications. This whole cell-based biosensor will enhance our understanding of the
responsiveness of cancer cells to electric field therapy and demonstrate potential
therapeutic opportunities for electric field therapy in the treatment of cancer.
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Chapter 5

TARGETED ELECTRICAL FIELD MANIPULATION OF CANCER CELLS
USING ANTIBODY FUNCTIONALIZED NANOPARTICLES
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5.1 Introduction
Electrical properties of cells determine most of the cellular functions,
predominantly proliferation and differentiation.

In particular, the transmembrane

potential, the voltage difference across the membrane produced by the balance of
intracellular and extracellular ionic concentrations, is responsible for controlling mitosis,
DNA synthesis, and the majority of other cell cycle phenomena [1]. Several studies have
previously been done to derive the relationship between transmembrane potential and cell
proliferation.

Initially, Cone and Tongier (1973) investigated the effects of

transmembrane modification on the mitotic activity of Chinese hamster ovary cells [2].
Their study showed that decreasing the cells transmembrane potential ultimately stopped
the mitotic process in the cells with the process being reversible once the transmembrane
potential returned to a normal value. More recently, MCF-7, human adenocarcinoma,
membranes have been shown to hyperpolarize during the G0/G1 phase of proliferation
[3]. Manipulation of these electrical properties may provide a powerful electrotherapy
option for the treatment of cancer as cancerous cells have been shown to have more
electronegative membrane potential than normal proliferating cells, thus, further studies
on cancer electrotherapy is warranted.
Previously, we used our EIS to explore the responses of cancerous SKOV3 cells
and normal HUVEC cells to low intensity (<2 V/cm) AC electric fields, determining that
the optimal frequency for SKOV3 proliferation arrest was 200 kHz, without harming the
non-cancerous HUVECs [4]. We observed a slower proliferation rate in the cancer cells
through the lower resistance curves of the EIS in real-time as the external field was
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applied compared to a control with no applied field, digital images of the cells on the EIS
electrode and florescence staining (propidium iodide) of the cells before and after
application of the external field. We now want to determine if these effects are cell type
dependant and so for this study, human breast adenocarcinoma cells (MCF7) were chosen
as another type of cancer cell for comparison as according to the American Cancer
Society, every year over 200,000 American women are diagnosed with breast cancer.
The MCF7, along with the non-cancerous MCF10a, were subjected to the range of
frequencies (50 kHz–2 MHz) similar to the previously tested SKOV3 and HUVEC to
determine the optimal frequency that would most hinder the proliferation of the MCF7.
Due to electrostatic forces, the interior of the cell has uniform potential and a
voltage drop across the plasma membrane. With the application of any external electric
field, the first electrostatic force encountered would be the membrane potential.
Cancerous cells have been shown to have lower cell and cytoplasmic conductivity as well
as a lower membrane capacitance compared to non-cancerous cells [5]. This outermost
electrically negative zone is composed of negatively charged sialic acid molecules found
on the tops of glycoproteins extending outward from the cell membrane. The zeta
potential, the potential that exists at the electrical double layer of a particle or cell, is
created from these sialic acid residues. Cancer cells have significantly more sialic acid
molecules and thus a greater surface negativity. Thus, any external factor that would
affect these residues would change the surface negativity of the cell.
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In 1990, Seeger and Wolz correlated the electronegativity of cancer cell
membranes with membrane degeneration throughout the process of carcinogenesis [6].
This process involves the degradation of the external cell membrane initially, causing
more permeability to water-soluble substances to potassium, magnesium, and calcium
migrate from the cells and sodium and water accumulate in the cell interior. This is then
followed by degenerative changes in the inner membrane of the mitochondria causing
loss of anchorage of critical mitochondrial enzymes. Since the membrane potential in a
cancer cell is lower than the membrane potential of a healthy cell, the electrical field
across the membrane of a cancer cell is reduced. The reduction in membrane electrical
field strength will in turn cause alterations in the metabolic functions of the cell.
The ultimate fate of these cells after they endure the effects of the applied field is
the next focus. We first sought to enhance the effects of the externally applied field by
incorporating HER2 antibody functionalized gold nanoparticles (HER2-AuNPs) to
specifically target the two types of cancer cells and monitor the real-time consequences
on cellular viability under the electric field using the EIS. Gold nanoparticles have been
extensively used in biomedical applications and studies due to their nontoxic properties,
and this was shown in our study of nanotoxicity in Chapter 2. HER2, human epidermal
growth factor receptor 2, is a cell membrane surface-bound receptor tyrosine kinase that
is responsible for intracellular signal transduction and ultimately cell growth and
differentiation [7]. HER2 overexpression leads to cancerous cell proliferation and is seen
in cancers such as breast cancer, ovarian cancer, stomach cancer, and even lung cancer
[8], and both SKOV3 and MCF7 cells overexpress HER2 markers on their surface
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membrane, so the HER2 antibody fit our study. The motivation behind specifically
targeting the cancer cells with the HER2-AuNPs is that the nanoparticles would bind to
the HER2 receptors on the membrane of the cancer cells, thus affecting the cells’ zeta
potential as the binding of charged nanoparticles to the cell surface plasma membrane
will change the zeta potential value of the cells. The zeta potential of the AuNPs, HER2AuNPS and cells before and after incorporation of the HER2-AuNPs will be taken to
monitor this phenomenon. We also expect to see a difference with the application of the
electric field to the combination of HER2-AuNPs and cell. We also intend to test the cell
death mechanism by using an Annexin V/ EthD-III assay to determine if the cells
undergo apoptosis or necrosis after the application of the applied electric field.
5.2 Experimental Details
5.2.1 Cell culture
HTB-77™ (SKOV3) and CRL-1730™ (HUVEC) cells were purchased from
American Type Culture Collection (ATCC, Rockville, MD, USA) and were cultured in
McCoy’s 5A Modified Medium and Dulbecco’s Modified Eagle Medium respectively,
each containing 10 % fetal bovine serum, 0.3 mg ml−1 L-glutamine, 100 U ml−1 penicillin
and 100 mg ml−1 streptomycin. The HTB-22™ (MCF7) and CRL-10317TM (MCF10a)
were graciously donated from the Research Institute at Miami Children's Hospital,
Miami, FL, and were both cultured in Eagle's Minimum Essential Medium containing 10
% fetal bovine serum, 0.3 mg ml−1 L-glutamine, 100 U ml−1 penicillin and 100 mg ml−1
streptomycin.

The cell cultures were placed in an incubator (37 °C, 5 % CO2

atmosphere) for 24 hours prior to the experiment so that the cells reached confluency
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with a final concentration of 105 cells ml−1. 0.4 ml of cell suspension was inoculated into
each well in the EIS chip for the experiments.
5.2.2 Electrical impedance sensing (EIS)
The EIS chip design was previously reported [4]. In short, individual tissue
culture wells of volume 9 × 9 × 10 mm3 are placed over an array of eight detecting gold
electrodes (250 µm in diameter) each linked to a gold counter electrode (7 × 46 mm2).
5.2.3 Application of external electric field
The design of the application of the external electric field to the EIS chip was
previously described [4]. In brief, a unique system of a pair of insulated wires (BLK
KYNAR 100’, conductor area 0.25 mm) was designed to be placed in conjunction with
the 8 well array design of the EIS chip. The wires were placed in 4 of the wells with the
other 4 wells used as the control. The wires were placed 1mm apart to allow spacing to
encompass the whole electrode area. Figure 2 shows a schematic of the wire setup and
the resulting electric field surrounding the electrodes. A Leader LFG-1300S Function
Generator was used to provide the square AC waves at the desired frequencies.
5.2.4 Synthesis of AuNPs
Hydrogen tetrachloroaurate (HAuCL4) (40 ml, 1.0 mM) was added to an
Erlenmeyer flask (250 ml), stirred and brought to the boil on a hotplate. Trisodium citrate
(Na3C6H5O7) (4 ml, 1%) was added to the boiling solution. Three minutes after the
addition of trisodium citrate, and 10 minutes of stirring, AuNPs were formed. The size of
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the AuNPs was characterized by the Zetasizer (Malvern Instruments, Woodstock, GA)
and found to be 20 nm.
5.2.5 HER2 antibody functionalization of AuNps
The HER2 antibody preparation was done following the procedure of Zhu et al.
[9]. The AuNPs solution was concentrated 5X and the pH of the AuNPs solution for
antibody labeling was adjusted to pH 8.5 ∼ 9.0 with 0.2 ml of K2CO3 (0.1 M). Purified

Anti-ErbB2/Her2 Monoclonal Antibody (5 µL, 1 mg mL-1) was added to the AuNPs
solution (750 µ L, 5X) and stirred gently at room temperature for 1 h. The conjugate was
stabilized by adding BSA (90 µ L, 10%) in sodium borate (20 mM) for a final
concentration of 1% and the solution was incubated for another 15 min. The mixture was
then centrifuged at 7000 rcf for 15 min. Two phases can be obtained: a clear to pink
supernatant of unbound antibodies and a dark red, loosely packed sediment of the
AuNPs-Abs conjugates. The supernatant was discarded and the pellet was resuspended in
BSA/PBS (100 µ L, 1%). After another centrifugation at 7000 rcf for 15 min, the
supernatant was removed and the pellet was resuspended in 100 buffer (100 µL),
containing sodium phosphate (20 mM), Tween 20 (0.25%), sucrose (10%), and BSA
(5%). The conjugate was stored at 4° C until required for use.
5.2.6 Apoptosis / Necrosis Assay
Apoptotic/Necrotic Cells Detection Kit was purchased from PromoKine
(Germany). The kit contains FITC-Annexin V in TE buffer containing 0.1% BSA and
0.1% NaN3 (pH 7.5), Ethidium Homodimer III (EthD-III) in PBS and 5X Binding Buffer.
A 1:5 dilution of Binding Buffer to DI water was made. After runs with the EIS, the cells
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were detached from the wells on the chip with 0.25% Trypsin/EDTA and suspended with
the 1:5 Binding Buffer/DI solution giving a final concentration of 105 cells ml−1. 100 µl
of the cell suspension was placed in a microcentrifuge tube to which 5 µl of FITCAnnexin V and 5 µl of Ethidium Homodimer III solutions were added to each tube. The
samples were incubated at room temperature for 15 minutes in the dark, after which the
cells were washed and resuspended with the 1:5 Binding Buffer/DI solution.
Fluorescence intensity was determined using a confocal microscope (Perkin Elmer
UltraView Vox system, USA) with FITC and Texas Red filter sets.
5.2.7 Zeta potential measurement
The Zetasizer Nano ZEN 3600 (Malvern Instruments, United Kingdom) was used
to measure the zeta potential of the AuNPs, HER2-AuNPS and the HER2-AuNPS with
each cell type, SKOV3, HUVEC, MCF7 and MCF10a.
5.3 Results
5.3.1 Optimal frequency for MCF7
As done before with the SKOV3 cells, the MCF7 and MCF10 cells were
subjected to five different frequencies of alternating electric fields 50, 100, 150 and 200
kHz and 2 MHz, to find the optimal frequency that would most hinder the growth of the
MCF7 cells without harming the normal MCF10a cells. Figure 5.1 shows the EIS results
of the MCF10a (5.1 (a), (c)) and the MCF7 (5.1 (b), (d)) for the intermediate frequencies
(100, 150, 200) and the extreme frequencies (50 kHz, 2 MHz) respectively.
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Figure 5.1 - Resistance values of MCF10a (a) and MCF7 (b) under electric fields of frequencies 100, 150
and 200 kHz. No apparent effect was noticed for the normal MCF10a, however, a significant decrease in
resistance values was observed for the MCF7 for all three frequencies. 50 kHz and 2 MHz frequencies were
tested on both MCF10a (c) and MCF7 (d). The MCF10a showed no apparent effect on the cell
proliferation as seen in the similar resistance curves to the control. 100 kHz showed the largest decrease out
of all the frequencies for the MCF7

The breast cancer cell lines behaved in a similar manner to the ovarian cancer cell
lines tested previously as did the noncancerous MCF10a to the HUVECs. Under the
influence of the electric field at all five frequencies, the resistance values for the MCF10a
cells followed a trend of proliferating cells gradually attaching and spreading across the
electrode surface creating an increase in resistance values. This can be seen in Figures
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5.1 (a) and (c) which show the resistance values of the MCF10a when exposed to the
intermediate range frequencies (100, 150, 200 kHz) and the extreme frequencies (50 kHz,
2 MHz) respectively. However, the MCF7 exhibited a variation of trends in resistance
profiles with the different frequencies of the applied field. Shown in Figure 5.1 (b), 150
and 200 kHz decreased the resistance profiles of the MCF7, however, the MCF7 have the
lowest resistance profile with 100 kHz indicating the most effect on the cell proliferation
at this frequency.

The extreme frequencies were also tested to justify that the

intermediate frequencies are the target frequencies suitable for cancer electrotherapy.
The MCF10a cells retained a similar profile with the applied field as without (Figure 5.1
(c)).

In Figure 5.1 (d), the MCF7 show more of a difference when the extreme

frequencies are applied compared to the previously tested SKOV3. The higher frequency
of 2 MHz had an effect on the MCF7 proliferation as can be seen in the lower resistance
profile compared to the control with no field applied. This could be due to the more
sensitive membrane of the MCF7 compared to that of the other types of cancer cells.
Cancer cells, in general, lower membrane potentials with lower stiffness compared to
their normal counterpart as was measured by the Young’s modulus though atomic force
microscopy (AFM) [10]. In addition, The MCF7 type of breast cancer cells was observed
to have a lower Young’s modulus in comparison with other types of cancer cells,
potentially giving the cells a weaker membrane.

50 KHz also slowed down the

proliferation of the MCF7 cells; however, the 100 kHz affected the proliferation of these
cells the most.
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5.3.2 HER2-AuNPs targeted enhancement
Gold nanoparticles are being use in targeted therapies in biomedical engineering
such as gene and drug delivery transfection vectors, DNA-binding agents and in various
imaging systems due to their inert properties [11]. In this study, we functionalized our
AuNPs with a HER2 antibody for a targeted delivery of the particles to the cell
membrane since HER2 is overexpressed in both breast and ovarian cancers. We tested
the two types of cancer cells, SKOV3 and MCF7, as well as the non-cancerous HUVECs
and MCF10a, under their respective optimal frequencies, 200 and 100 KHz, with and
without the integration if the HER2-AuNPS to determine any enhancement in the effects
of the applied electric field.
The first concern with using the metallic nanoparticles under the applied electric
field would be the potential heating of the nanoparticles. AuNPS are being used for
cancer hyperthermia studies [12], however, these studies use nearinfrared (NIR) laser
light, [13] radiowaves, [14] or even ultrasound [15]. To make sure temperature would
not be a factor for the cancer cells under the intermediate frequencies determined for the
two types of cancer cells, we tested the temperature of the wells at incremental times of 6
hours for the SKOV3 and 4 hours for the MCF7 for an entire run. Figure 5.2 (a) and (b)
shows the average temperature of the 8 wells on one chip for the SKOV3 and the MCF7,
respectively. Here we do not see any significant change in temperature when the HER2AuNPS were incorporated for either type of cell, indicating no apparent thermal effects
from the nanoparticles.
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Figure 5.2 – Average temperature readings for the 8 wells on a chip at various time points
throughout an EIS run for SKOV3 (a) and MCF7 (b)

Figure 5.3 (a) and (c) shows the resistance values obtained for the noncancerous
HUVECs and MCF10a, respectively.

As in the previous experiment, there is no

noticeable change in the resistance values when the electric field was applied to the cells
compared to the control cells with now applied field. Also, with the incorporation of the
HER2-AuNPs, there is still no apparent effect in the resistance profiles. However, a
noticeable decrease in the growth profiles of the SKOV3 and MCF7 was observed with
the application of the HER2-AuNPs and the electric fields compared to just the field itself
indicating specific inhibitory effects on dividing cells in culture (Figure 5.3 (b) and (d)).
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Figure 5.3 – Resistance values for HUVECs (a), SKOV3 (b), MCF10a (c) and MCF7 (d) under the
effects of the optimal frequencies (SKOV3 200kHz, MCF7 100kHz) with and without the application
of HER2-AuNPS

5.3.3 Apoptosis / Necrosis Assay
Apoptosis and necrosis are the two major processes leading to cell death.
Apoptosis is the process of programmed cell death caused by a cascade of biochemical
signals within the cell and can be triggered from a variety of external factors usually in
the form of stress towards the cell. In the case of apoptosis, the cell prepares itself by
performing changes within, one of them being changes in the phospholipid content of the
cell membrane.
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Apoptotic cells can be easily identified with the protein Annexin V, which is
binds to phosphatidylserine, a protein located in the cell membrane. Under normal
circumstances, the phosphatidylserine is found in the inner layer of the cell membrane
double layer. In the early stages of apoptosis, these phosphatidylserine proteins move to
the outer layer of the membrane where Annexin V labeled with fluorescein (FITC) can
bind, staining apoptotic cells green.
Necrosis is a traumatic cell death that results from any acute damage caused to the
cell where the cell membrane integrity is compromised. This results in the cytosol and
organelles within the cell to spill into the surrounding environment. Ethidium homodimer
III (EthD-III) is a highly positively charged nucleic acid probe which binds to DNA, thus
is used to classify necrotic cells by staining them with red fluorescence.
To further understand the effects of the externally applied field to the cells, an
Annexin V/ EthD-III assay was performed to determine the cell death mechanism with
green fluorescent membrane staining indicating apoptotic cells, and red fluorescent
nuclear staining necrotic cells. Figure 5.4 shows the fluorescent staining of MCF7 cells
after 20 hours of exposure to 100 kHz electric field. The image on the left shows EthD-III
stained cells (necrotic) and the image on the right shows Annexin V stained cells
(apoptotic). There are significantly more cells stained with the Annexin V indicating the
death mechanism triggered from the applied electric field to be apoptosis.
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Figure 5.4 – Fluorescent staining of MCF7 cells after 20 hours of exposure to 100 kHz electric field.
The image on the left shows EthD-III stained cells (necrotic) and the image on the right shows
Annexin V stained cells (apoptotic).

5.3.4 Zeta Potential Measurements
In order to understand the effects of the applied electric field with targeted
nanoparticle enhancement, the next focus of the study was to observe the zeta potential of
the cells before and after exposure to the nanoparticles. Zeta potential is the electrostatic
potential near the surface of a particle and usually this surface charge is counterbalanced
by charges of opposite sign in the surrounding solution. With the nanoparticles, once in
contact with the cell membrane, the surface charges of the particles may affect the cells
membrane properties with negatively charged ions or molecules will decrease and
positively charged ions will increase the surface zeta potential of the cell [16-17], thus
attachment of negatively charged nanoparticles on the cell’s membrane will cause its zeta
potential to become more negative.
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We measured the zeta potential of our AuNPs before and after functionalization
with the HER2 antibody to see if the antibody would affect the nanoparticles’ zeta
potential. We then measured the zeta potential of the two cancer cell lines, SKOV3 and
MCF7, with and without the incorporation of the HER2-AuNPS and compared the results
to those for the non-cancerous cell lines, HUVEC and MCF10a, respectively (Figure
5.5). In all cases, the bare AuNPS had the lowest zeta potentials with values of -37.4 ±
0.7, -40.0 ± 0.05, -43.3 ± 0.7, and -39.3 ± 0.4 as shown in Figure 5.5 (a), (b), (c) and (d),
respectively.

With the functionalization of the HER2 antibody, the zeta potentials

increased slightly for each case (-30.5 ± 1.4, -37.1 ± 1.2, -41.6 ± 1.0, -35.5 ± 0.6). The
cells themselves had initial zeta potentials of -19.2 ± 0.9 (HUVEC), -19.3 ± 0.8
(SKOV3), - 20.5 ± 0.9 (MCF10a) and -28.3 ± 1.3 (MCF7). After incubation with the
HER2-AuNPS, the cancerous cell showed a significant decrease in zeta potentials
compared to the non-cancerous cells.

For the HUVECs, the zeta potential slightly

increased to -18.3 ± 0.9, and the MCF10a also showed a slight increase to -18.9 ±
2.3.(Figure 5.5 (a), (c), respectively). The case was different for both cancerous cell
types as the zeta potentials dropped after HER2-AuNPS functionaliztion for the SKOV3
to -25.3 ± 1.3, and for the MCF7 to -37.6 ± 1.3 (Figure 5.5 (b), (d), respectively).
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Figure 5.5 – Zeta potential values for HUVECs (a), SKOV3 (b), MCF10a (c), and MCF7 (d). With
the integration of the HER2-AuNPs, the zeta potential of both cancer cells decreased in comparison
to the two noncancerous cell types.

5.4 Discussion
The cell membrane provides a barrier for the cell and its surroundings and as a
result is the first line of defense for the cell to survive. The membrane controls the
exchange of electrically charged ions across the cell membrane thus creating the cell
membrane potential. It is this potential that is the underlying characteristic of the cell that
could distinguish between normal and cancerous cells. It was been noted before that
cancerous cell have a lower membrane potential, and it has been shown that the cell’s
membrane changes during cancer transformation, in particular the membrane’s fluidity
and charge [18-19].

Therefore, by altering the cell membrane potential, one could

possibly control the fate of the cell.
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Cancerous cell membranes have a higher number of negatively charged sialic
acids, which regulate intercellular contacts and the interaction of charged
macromolecules with the cell surface [20]. It is the number of sialic acids that lead to any
cell’s overall negative membrane potential and ultimately determines a cell’s zeta
potential [21]. Sialyation is one of the factors that cause the cancer cell membrane to be
more electronegative and consequently, any factor that increases or decreases the number
of sialic acid residues will change the degree of membrane negativity.
We had proposed that gold nanoparticles functionalized with specific antibodies
to target the cancer cells would enhance the effects of the electric field towards the cells
without affecting the non-cancerous cells due to the different membrane properties of the
cancerous cells. In our study, the antibody used targeted HER2 glycoprotein receptor on
the cell membrane.

Since sialic acids are generally found at the end of most

glycoproteins, and the specific cancer cells tested overexpress the HER2 receptor, we can
deduce that there would be more HER2-AuNPs attracted to the cancer cells as opposed to
the regular cells. With more negatively charged HER2-AuNPs attached to the cancer cell
membrane, the cell membrane could more vulnerable to the effects of the external electric
field due to the decrease in surface charge. An important consequence of the existence of
electrical charges on the surface of particles is that they will exhibit certain effects under
the influence of an applied electric field. Since the changes in zeta potential values
depend on cell surface charge, nanoparticle surface charge and their interaction we
observed a decrease in zeta potentials of the cells after nanoparticle incorporation leaving
the cells more vulnerable to the detrimental effects of the applied electric field.
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There was also a noticeable difference in the behavior between the two types of
cancer cells. The breast cancer cell line, MCF7 was affected by a lower frequency than
the ovarian cancer cell line, SKOV3. This could be due to the MCF7 having a more
simplified cytoskeleton compared with MCF10A, which results in less stiffness and
easier deformation [22].
5.5 Conclusion
Cancer electrotherapy treatments are showing considerable promise to avoid the
negative side effects of traditional cancer treatments such as chemotherapy.

We

previously demonstrated that cancer cell proliferation is affected by externally applied
alternating electric fields in the intermediate frequency range of 100 kHz – 200 kHz. In
this study, we demonstrated that different types of cancer cells are affected by different
optimal frequencies of these electric fields. To further understand the effects of the
applied fields on the cells, we performed an Annexin V/ EthD-III assay to conclude the
fate of the cells as apoptosis. We also observed a decrease in proliferation with the
addition of HER2-AuNPs to target the cancer cells and enhance the effects of the electric
field towards the cells without affecting the non-cancerous cells.

With the attached

nanoparticles, the zeta potential of the SKOV3 and the MCF7 before and after
incorporation of the HER2-AuNPs decreased compared to their non-cancerous
counterparts. The decrease in membrane potential would thus leave the cells more
vulnerable to the detrimental effects of the applied electric field. The outcome of this
research will improve our fundamental understanding of the behavior of cancer cells and
define optimal parameters of electrotherapy for clinical and drug delivery applications.
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Chapter 6

CONCLUSIONS
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In this doctoral study, a whole cell electrical impedance sensing (EIS) biosensor
was used to analyze the cell behavior in real-time. The biosensor proved to be a rapid
technique to get more information about living cells without disturbing the cellular subsystems creating a versatile, noninvasive tool that is able to provide quantitative
information with respect to alteration in cellular function when subjected to the various
stimuli.
The capability of the biosensor to monitor the cellular behavior was first
demonstrated in Chapters 2 and 3 by testing human and environmental toxicity of
nanoscale materials in 2D and 3D cell culture models. These studies also provided insight
on the ability of the EIS biosensor to monitor the kinetic effects of the cellular reaction
pattern towards various nanoparticles, allowing better understanding of the nanoparticlecell interaction over time. Results indicated that the EIS chip exhibited a stable and
reproducible response when measuring the effects of various nanomaterials—AuNPs (10,
100 nm), AgNPs (10, 100 nm), SWCNTs (cut, uncut) and CdO—towards CCL-153 and
RTgill-W1 cells.
After the initial nanotoxicity studies, the biosensor was ultimately used to test the
effects of external alternating electric fields in combination with antibody targeted
nanoparticle therapy on the behavior of cancer cells as seen in chapters 4 and 5.
Electrotherapy for cancer treatment is very promising alternative to traditional methods
such as chemotherapy since as it eliminates the toxic chemicals and possible
immunogenic responses in the host tissue. The cancer electrotherapy study improved our
fundamental understanding of the behavior of cancer cells to alternating electric fields by
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showing that a low intensity electric field at 200 kHz frequency has a detrimental effect
on cancerous SKOV3 cells without affecting the non-cancerous HUVEC cells. We also
demonstrated that the applied electric field affects different types of cancer cells at
different frequencies as seen with the MCF7 cells and their optimal frequency of 100
kHZ.
We then sought to enhance the effects of the electric field by altering the cancer
cell’s electronegative membrane properties with antibody functionalized nanoparticles.
With the attached nanoparticles, the zeta potential of the SKOV3 and the MCF7 before
and after incorporation of the HER2-AuNPs decreased compared to their non-cancerous
counterparts. The decrease in membrane potential would thus leave the cells more
vulnerable to the detrimental effects of the applied electric field.

This research and

allowed us to define a strategy and optimal parameters of antibody targeted nanoparticle
electrotherapy for clinical and drug delivery applications. The outcome of this research
will improve our fundamental understanding of the behavior of cancer cells to alternating
electric fields and define a strategy and optimal parameters of electrotherapy for clinical
and drug delivery applications. This whole cell-based biosensor will enhance our
understanding of the responsiveness of cancer cells to electric field therapy and
demonstrate potential therapeutic opportunities for electric field therapy in the treatment
of cancer.
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